CAMK1A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O00429 | S637 | SIGNOR | DNM1L DLP1 DRP1 | PQKGHAVNLLDVPVPVARKLsAREQRDCEVIERLIKSYFLI |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O43432 | S1156 | SIGNOR|iPTMNet|PSP | EIF4G3 | KNDKPLPSATARPNTFMRGGssKDLLDNQsQEEQRREMLET |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05783 | S53 | SIGNOR|ELM | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17600 | S9 | SIGNOR|iPTMNet | SYN1 | ____________MNYLRRRLsDSNFMANLPNGYMTDLQRPQ |
| P18206 | S1002 | Sugiyama | VCL | SKGNDIIAAAKRMALLMAEMsRLVRGGSGTKRALIQCAKDI |
| P18846 | S63 | SIGNOR|iPTMNet | ATF1 | DsSDsIGssQKAHGILARRPsYRKILKDLsSEDTRGRKGDG |
| P19474 | S3 | Sugiyama | TRIM21 RNF81 RO52 SSA1 | __________________MAsAARLTMMWEEVTCPICLDPF |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24844 | S20 | PSP | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P29475 | S746 | iPTMNet | NOS1 | GTPTKRRAIGFKKLAEAVKFsAKLMGQAMAKRVKATILYAT |
| P29475 | S852 | SIGNOR|iPTMNet | NOS1 | EMRHPNSVQEERKSYKVRFNsVSSYSDsQKSSGDGPDLRDN |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P35968 | Y951 | Sugiyama | KDR FLK1 VEGFR2 | KRNEFVPYKTKGARFRQGKDyVGAIPVDLKRRLDSITSSQS |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39019 | S59 | PSP | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | T1764 | Sugiyama | MKI67 | LVDtPtssKPQPKRSLRKADtEEEFLAFRKQTPSAGKAMHt |
| P46527 | T157 | SIGNOR|PSP | CDKN1B KIP1 p27 | PsDsQTGLAEQCAGIRKRPAtDDSSTQNKRANRTEENVsDG |
| P46527 | T198 | SIGNOR|PSP | CDKN1B KIP1 p27 | sPNAGSVEQtPKKPGLRRRQt____________________ |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49757 | S276 | SIGNOR | NUMB C14orf41 | NNPHAIPRRHAPIEQLARQGsFRGFPALsQKMSPFKRQLsL |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q05209 | S435 | Sugiyama | PTPN12 | LPGKNESTIEQIDKKLERNLsFEIKKVPLQEGPKsFDGNtL |
| Q05469 | S855 | PSP | LIPE | SGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKNLT |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q09472 | S89 | ELM | EP300 P300 | GMVQDAASKHKQLSELLRsGssPNLNMGVGGPGQVMAsQAQ |
| Q13085 | S25 | ELM | ACACA ACAC ACC1 ACCA | sPLAQPLELNQHSRFIIGsVsEDNsEDEISNLVKLDLLEEK |
| Q14012 | S324 | Sugiyama | CAMK1 | KQAFNAtAVVRHMRKLQLGtsQEGQGQtAsHGELLtPVAGG |
| Q14012 | S333 | Sugiyama | CAMK1 | VRHMRKLQLGtsQEGQGQtAsHGELLtPVAGGPAAGCCCRD |
| Q14012 | S363 | Sugiyama | CAMK1 | GGPAAGCCCRDCCVEPGtELsPtLPHQL_____________ |
| Q14012 | T177 | SIGNOR|ELM|iPTMNet | CAMK1 | KIMISDFGLSKMEDPGSVLstACGTPGYVAPEVLAQKPYSK |
| Q14012 | T310 | Sugiyama | CAMK1 | VSEQIKKNFAKSKWKQAFNAtAVVRHMRKLQLGtsQEGQGQ |
| Q14012 | T323 | Sugiyama | CAMK1 | WKQAFNAtAVVRHMRKLQLGtsQEGQGQtAsHGELLtPVAG |
| Q14012 | T331 | Sugiyama | CAMK1 | AVVRHMRKLQLGtsQEGQGQtAsHGELLtPVAGGPAAGCCC |
| Q14012 | T339 | Sugiyama | CAMK1 | LQLGtsQEGQGQtAsHGELLtPVAGGPAAGCCCRDCCVEPG |
| Q14012 | T365 | Sugiyama | CAMK1 | PAAGCCCRDCCVEPGtELsPtLPHQL_______________ |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q16566 | T200 | ELM | CAMK4 CAMK CAMK-GR CAMKIV | PLKIADFGLsKIVEHQVLMKtVCGTPGYCAPEILRGCAYGP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q5UIP0 | S1688 | Sugiyama | RIF1 | PVPESNLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssL |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8IU85 | T313 | Sugiyama | CAMK1D CAMKID | VSAQIRKNFAKSKWRQAFNAtAVVRHMRKLHLGssLDssNA |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8WVC0 | T477 | Sugiyama | LEO1 RDL | FDVYKAPLQGDHNHLFIRQGtGLQGQAVFKTKLTFRPHstD |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9NP62 | S177 | PSP | GCM1 GCMA | PETKLEAEARRAMKKVNtAPssVSLSLKGSTETRSLPGETQ |
| Q9NP62 | S178 | PSP | GCM1 GCMA | ETKLEAEARRAMKKVNtAPssVSLSLKGSTETRSLPGETQS |
| Q9NP62 | S269 | PSP | GCM1 GCMA | DLTDQTSTVDPMKLYEKRKLsSSRTYsSGDLLPPSASGVYS |
| Q9NP62 | S47 | SIGNOR|PSP | GCM1 GCMA | VKKTDWFQEWPDSYAKHIYSsEDKNAQRHLSSWAMRNTNNH |
| Q9NP62 | T174 | PSP | GCM1 GCMA | HPKPETKLEAEARRAMKKVNtAPssVSLSLKGSTETRSLPG |
| Q9NY27 | S311 | Sugiyama | PPP4R2 SBBI57 | CTRQHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDD |
| Q9NY27 | S315 | Sugiyama | PPP4R2 SBBI57 | HCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALTV |
| Q9NY27 | T297 | Sugiyama | PPP4R2 SBBI57 | EAssssQDKDKDSRCTRQHCtEEDEEEDEEEEEEsFMtsRE |
| Q9NY27 | T314 | Sugiyama | PPP4R2 SBBI57 | QHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALT |
| Q9UKV0 | S220 | PSP | HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR | KYTLPGAQDAKDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UKV0 | S451 | PSP | HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR | SPGIRGTHKLPRHRPLNRtQsAPLPQSTLAQLVIQQQHQQF |
| Q9UQL6 | S259 | SIGNOR|iPTMNet|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR|iPTMNet|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y570 | S15 | SIGNOR|PSP | PPME1 PME1 PP2593 PRO0750 | ______MSALEKSMHLGRLPsRPPLPGsGGsQsGAKMRMGP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 3.223118e-10 | 9.492 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.410315e-08 | 7.851 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.017579e-08 | 7.096 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.132031e-07 | 6.039 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.576396e-07 | 6.067 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.549650e-06 | 5.810 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.062083e-06 | 5.686 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.416167e-06 | 5.355 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.919730e-06 | 5.308 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.817418e-06 | 5.055 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.835229e-06 | 5.007 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.130612e-05 | 4.947 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.260549e-05 | 4.899 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.291030e-05 | 4.889 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.402063e-05 | 4.619 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.026941e-05 | 4.519 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.026941e-05 | 4.519 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.331712e-05 | 4.477 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.578633e-05 | 4.446 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.662717e-05 | 4.176 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.045533e-04 | 3.981 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.274023e-04 | 3.895 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.495931e-04 | 3.825 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.575741e-04 | 3.803 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.587428e-04 | 3.799 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.719463e-04 | 3.765 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.782711e-04 | 3.749 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.488518e-04 | 3.604 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.822199e-04 | 3.549 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.311922e-04 | 3.480 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.794152e-04 | 3.421 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.856162e-04 | 3.414 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.710301e-04 | 3.173 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.537480e-04 | 3.185 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.624715e-04 | 3.179 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.913004e-04 | 3.160 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.829698e-04 | 3.106 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.128725e-04 | 3.090 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.593153e-04 | 3.066 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.431123e-04 | 3.025 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.096936e-03 | 2.960 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.200725e-03 | 2.921 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.231603e-03 | 2.910 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.298953e-03 | 2.886 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.360766e-03 | 2.866 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.523463e-03 | 2.817 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.523463e-03 | 2.817 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.523463e-03 | 2.817 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.523463e-03 | 2.817 | 1 | 1 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.748547e-03 | 2.757 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.653325e-03 | 2.782 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.742721e-03 | 2.759 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.742721e-03 | 2.759 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.777581e-03 | 2.750 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.777581e-03 | 2.750 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.894044e-03 | 2.723 | 1 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.235955e-03 | 2.651 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.486508e-03 | 2.604 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.529714e-03 | 2.597 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.801047e-03 | 2.553 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.895054e-03 | 2.538 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.144652e-03 | 2.502 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.539513e-03 | 2.451 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.539513e-03 | 2.451 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.560246e-03 | 2.449 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.001336e-03 | 2.398 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.051656e-03 | 2.392 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.220153e-03 | 2.375 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.352703e-03 | 2.361 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.214577e-03 | 2.375 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.560564e-03 | 2.341 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.560564e-03 | 2.341 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.560564e-03 | 2.341 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.592120e-03 | 2.338 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.152132e-03 | 2.288 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.196177e-03 | 2.284 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.615593e-03 | 2.251 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.690146e-03 | 2.245 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.192081e-03 | 2.208 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.168213e-03 | 2.145 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.238823e-03 | 2.140 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.766569e-03 | 2.110 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.017199e-03 | 2.096 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.202527e-03 | 2.086 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.758076e-03 | 2.058 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 8.758076e-03 | 2.058 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 9.454622e-03 | 2.024 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.454622e-03 | 2.024 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.669815e-03 | 2.015 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.493257e-03 | 2.023 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.010669e-02 | 1.995 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.014568e-02 | 1.994 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.018047e-02 | 1.992 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.057727e-02 | 1.976 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.097622e-02 | 1.960 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.082106e-02 | 1.966 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.057727e-02 | 1.976 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.083768e-02 | 1.965 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.105168e-02 | 1.957 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.119999e-02 | 1.951 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.148167e-02 | 1.940 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.178811e-02 | 1.929 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.187466e-02 | 1.925 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.215215e-02 | 1.915 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.215215e-02 | 1.915 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.296342e-02 | 1.887 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.585569e-02 | 1.800 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.585569e-02 | 1.800 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.585569e-02 | 1.800 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.501205e-02 | 1.824 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.480984e-02 | 1.829 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.532554e-02 | 1.815 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.392564e-02 | 1.856 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.392564e-02 | 1.856 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.392564e-02 | 1.856 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.418577e-02 | 1.848 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.556606e-02 | 1.808 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.448388e-02 | 1.839 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.515872e-02 | 1.819 | 1 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.501205e-02 | 1.824 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.480984e-02 | 1.829 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.451189e-02 | 1.838 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.392564e-02 | 1.856 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.385983e-02 | 1.858 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.598390e-02 | 1.796 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.625571e-02 | 1.789 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.671351e-02 | 1.777 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.770594e-02 | 1.752 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.841157e-02 | 1.735 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.051709e-02 | 1.688 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.051709e-02 | 1.688 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.943945e-02 | 1.711 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.052003e-02 | 1.688 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.984565e-02 | 1.702 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.154745e-02 | 1.667 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.626379e-02 | 1.581 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.626379e-02 | 1.581 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.626379e-02 | 1.581 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.626379e-02 | 1.581 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.626379e-02 | 1.581 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.601812e-02 | 1.585 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.601812e-02 | 1.585 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.601812e-02 | 1.585 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.524768e-02 | 1.598 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.616685e-02 | 1.582 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.354160e-02 | 1.628 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.342254e-02 | 1.630 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.442444e-02 | 1.612 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.661629e-02 | 1.575 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.537538e-02 | 1.596 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.601812e-02 | 1.585 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.525043e-02 | 1.598 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.527493e-02 | 1.597 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.601812e-02 | 1.585 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.300296e-02 | 1.638 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.693179e-02 | 1.570 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.733853e-02 | 1.563 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.776066e-02 | 1.557 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.783550e-02 | 1.555 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.815179e-02 | 1.550 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.866700e-02 | 1.543 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.897006e-02 | 1.538 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.922496e-02 | 1.534 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.184662e-02 | 1.497 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.184662e-02 | 1.497 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.188501e-02 | 1.496 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.188501e-02 | 1.496 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.262216e-02 | 1.486 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.188501e-02 | 1.496 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.188501e-02 | 1.496 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.226230e-02 | 1.491 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.156540e-02 | 1.501 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.184662e-02 | 1.497 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.946165e-02 | 1.531 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.326632e-02 | 1.478 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.326632e-02 | 1.478 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.355220e-02 | 1.474 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.359334e-02 | 1.474 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.359334e-02 | 1.474 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.416187e-02 | 1.466 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.513847e-02 | 1.454 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.604491e-02 | 1.443 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.621498e-02 | 1.441 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.042576e-02 | 1.393 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.934497e-02 | 1.405 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.934497e-02 | 1.405 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.934497e-02 | 1.405 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.934497e-02 | 1.405 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.934497e-02 | 1.405 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.934497e-02 | 1.405 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.736300e-02 | 1.428 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.045635e-02 | 1.393 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.814947e-02 | 1.419 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.934497e-02 | 1.405 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.883024e-02 | 1.411 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.115203e-02 | 1.386 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.003078e-02 | 1.398 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.181606e-02 | 1.379 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.217554e-02 | 1.375 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.343690e-02 | 1.362 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.343690e-02 | 1.362 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.343690e-02 | 1.362 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.354249e-02 | 1.361 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.354249e-02 | 1.361 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.578121e-02 | 1.339 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.679580e-02 | 1.330 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.769754e-02 | 1.322 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.858749e-02 | 1.313 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.899253e-02 | 1.310 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.899253e-02 | 1.310 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.096640e-02 | 1.293 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.135568e-02 | 1.289 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.160564e-02 | 1.287 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.176295e-02 | 1.286 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.515891e-02 | 1.258 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.515891e-02 | 1.258 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.288157e-02 | 1.201 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.288157e-02 | 1.201 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.334807e-02 | 1.198 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.651857e-02 | 1.248 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.044195e-02 | 1.219 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.625370e-02 | 1.250 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.820910e-02 | 1.235 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.866359e-02 | 1.232 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.019555e-02 | 1.220 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.541645e-02 | 1.184 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.541645e-02 | 1.184 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.565239e-02 | 1.183 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.565239e-02 | 1.183 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.675511e-02 | 1.176 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.840027e-02 | 1.165 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.932580e-02 | 1.159 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 7.067828e-02 | 1.151 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 7.067828e-02 | 1.151 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 7.067828e-02 | 1.151 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.067828e-02 | 1.151 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.104187e-02 | 1.148 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.104187e-02 | 1.148 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.118424e-02 | 1.148 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.217500e-02 | 1.085 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 8.217500e-02 | 1.085 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 8.217500e-02 | 1.085 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.566246e-02 | 1.121 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.566246e-02 | 1.121 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.566246e-02 | 1.121 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.349249e-02 | 1.078 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.349249e-02 | 1.078 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.349249e-02 | 1.078 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.545657e-02 | 1.122 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.545657e-02 | 1.122 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.969774e-02 | 1.099 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.210868e-02 | 1.086 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.287840e-02 | 1.137 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.032620e-02 | 1.095 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.827457e-02 | 1.106 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.369832e-02 | 1.133 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.222768e-02 | 1.141 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.545657e-02 | 1.122 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.349249e-02 | 1.078 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.210868e-02 | 1.086 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.484075e-02 | 1.126 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.545657e-02 | 1.122 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.659918e-02 | 1.116 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.740726e-02 | 1.058 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.808037e-02 | 1.055 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.940043e-02 | 1.049 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.940043e-02 | 1.049 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 9.156220e-02 | 1.038 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 9.156220e-02 | 1.038 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.156220e-02 | 1.038 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.264486e-02 | 1.033 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.459277e-01 | 0.836 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.459277e-01 | 0.836 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.459277e-01 | 0.836 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.459277e-01 | 0.836 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.321749e-01 | 0.879 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.321749e-01 | 0.879 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.321749e-01 | 0.879 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.321749e-01 | 0.879 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.321749e-01 | 0.879 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.705677e-01 | 0.568 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.705677e-01 | 0.568 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.705677e-01 | 0.568 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.705677e-01 | 0.568 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.705677e-01 | 0.568 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.705677e-01 | 0.568 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.705677e-01 | 0.568 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.705677e-01 | 0.568 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.003799e-01 | 0.998 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.003799e-01 | 0.998 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.003799e-01 | 0.998 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.003799e-01 | 0.998 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.871303e-01 | 0.728 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.871303e-01 | 0.728 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.341588e-01 | 0.872 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.240016e-01 | 0.907 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.240016e-01 | 0.907 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.240016e-01 | 0.907 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.712217e-01 | 0.766 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.712217e-01 | 0.766 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.712217e-01 | 0.766 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.445316e-01 | 0.612 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.445316e-01 | 0.612 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.445316e-01 | 0.612 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.445316e-01 | 0.612 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.445316e-01 | 0.612 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.445316e-01 | 0.612 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.770243e-01 | 0.424 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.770243e-01 | 0.424 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.770243e-01 | 0.424 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.770243e-01 | 0.424 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.770243e-01 | 0.424 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.770243e-01 | 0.424 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.770243e-01 | 0.424 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.770243e-01 | 0.424 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.770243e-01 | 0.424 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.770243e-01 | 0.424 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.770243e-01 | 0.424 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.770243e-01 | 0.424 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.770243e-01 | 0.424 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.770243e-01 | 0.424 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.770243e-01 | 0.424 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.770243e-01 | 0.424 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.770243e-01 | 0.424 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.119186e-01 | 0.951 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.119186e-01 | 0.951 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.119186e-01 | 0.951 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.119186e-01 | 0.951 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.119186e-01 | 0.951 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.119186e-01 | 0.951 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.119186e-01 | 0.951 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.520405e-01 | 0.818 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.520405e-01 | 0.818 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.520405e-01 | 0.818 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.520405e-01 | 0.818 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.001826e-01 | 0.999 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.107702e-01 | 0.676 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.107702e-01 | 0.676 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.107702e-01 | 0.676 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.342468e-01 | 0.872 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.342468e-01 | 0.872 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.342468e-01 | 0.872 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.822111e-01 | 0.739 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.822111e-01 | 0.739 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.822111e-01 | 0.739 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.822111e-01 | 0.739 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.822111e-01 | 0.739 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.822111e-01 | 0.739 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.024954e-01 | 0.519 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.024954e-01 | 0.519 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.024954e-01 | 0.519 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.024954e-01 | 0.519 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.024954e-01 | 0.519 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.046950e-01 | 0.980 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.046950e-01 | 0.980 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.046950e-01 | 0.980 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.046950e-01 | 0.980 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.046950e-01 | 0.980 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.583804e-01 | 0.800 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.583804e-01 | 0.800 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.520406e-01 | 0.599 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.520406e-01 | 0.599 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.213041e-01 | 0.916 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.213041e-01 | 0.916 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.213041e-01 | 0.916 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.067244e-01 | 0.972 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.141441e-01 | 0.669 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.141441e-01 | 0.669 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.841263e-01 | 0.735 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.219125e-01 | 0.914 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.219125e-01 | 0.914 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.071782e-01 | 0.970 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.071782e-01 | 0.970 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.211589e-01 | 0.917 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.211589e-01 | 0.917 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.821927e-01 | 0.739 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.112725e-01 | 0.675 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.112725e-01 | 0.675 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.474624e-01 | 0.606 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.474624e-01 | 0.606 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.943295e-01 | 0.531 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.943295e-01 | 0.531 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.943295e-01 | 0.531 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.943295e-01 | 0.531 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.943295e-01 | 0.531 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.596357e-01 | 0.444 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.596357e-01 | 0.444 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.596357e-01 | 0.444 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.596357e-01 | 0.444 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.596357e-01 | 0.444 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.596357e-01 | 0.444 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.679494e-01 | 0.330 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 4.679494e-01 | 0.330 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.679494e-01 | 0.330 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.679494e-01 | 0.330 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.679494e-01 | 0.330 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.679494e-01 | 0.330 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.679494e-01 | 0.330 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.679494e-01 | 0.330 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.554611e-01 | 0.808 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.554611e-01 | 0.808 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.173583e-01 | 0.930 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.395953e-01 | 0.621 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.395953e-01 | 0.621 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.395953e-01 | 0.621 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.817938e-01 | 0.550 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.817938e-01 | 0.550 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.817938e-01 | 0.550 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.926007e-02 | 1.003 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.926007e-02 | 1.003 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.370085e-01 | 0.472 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.370085e-01 | 0.472 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.091356e-01 | 0.962 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.928787e-01 | 0.715 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.928787e-01 | 0.715 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.928787e-01 | 0.715 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.632234e-01 | 0.787 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.688652e-01 | 0.570 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.217300e-01 | 0.654 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.860568e-01 | 0.730 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.128698e-01 | 0.672 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.167802e-01 | 0.499 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.149589e-01 | 0.382 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.149589e-01 | 0.382 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 4.149589e-01 | 0.382 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.149589e-01 | 0.382 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.043044e-01 | 0.690 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.043044e-01 | 0.690 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.043044e-01 | 0.690 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.446556e-01 | 0.611 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.446556e-01 | 0.611 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.960892e-01 | 0.708 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.795310e-01 | 0.421 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.795310e-01 | 0.421 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.795310e-01 | 0.421 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.795310e-01 | 0.421 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.135224e-01 | 0.671 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.135224e-01 | 0.671 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.135224e-01 | 0.671 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.668325e-01 | 0.778 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.682772e-01 | 0.571 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.682772e-01 | 0.571 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.682772e-01 | 0.571 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.550192e-01 | 0.593 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.520859e-01 | 0.453 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.520859e-01 | 0.453 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.483060e-01 | 0.829 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.293335e-01 | 0.482 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.273137e-01 | 0.895 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.097460e-01 | 0.509 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.924777e-01 | 0.534 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.924777e-01 | 0.534 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.924777e-01 | 0.534 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.778483e-01 | 0.750 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.501394e-01 | 0.602 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.076424e-01 | 0.683 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.076424e-01 | 0.683 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.864850e-01 | 0.729 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.370925e-01 | 0.472 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.370925e-01 | 0.472 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.600912e-01 | 0.444 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.600912e-01 | 0.444 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.874021e-01 | 0.412 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.874021e-01 | 0.412 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.214333e-01 | 0.375 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.677785e-01 | 0.330 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.677785e-01 | 0.330 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.677785e-01 | 0.330 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.677785e-01 | 0.330 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.677785e-01 | 0.330 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.677785e-01 | 0.330 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.677785e-01 | 0.330 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.677785e-01 | 0.330 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.677785e-01 | 0.330 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.677785e-01 | 0.330 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.456082e-01 | 0.263 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.456082e-01 | 0.263 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.456082e-01 | 0.263 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.456082e-01 | 0.263 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.456082e-01 | 0.263 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.456082e-01 | 0.263 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 5.456082e-01 | 0.263 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.456082e-01 | 0.263 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.456082e-01 | 0.263 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.456082e-01 | 0.263 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 5.456082e-01 | 0.263 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.456082e-01 | 0.263 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.456082e-01 | 0.263 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.456082e-01 | 0.263 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.749220e-01 | 0.757 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.608401e-01 | 0.584 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.421427e-01 | 0.466 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.421427e-01 | 0.466 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.909221e-01 | 0.408 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.909221e-01 | 0.408 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.455077e-01 | 0.462 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.455077e-01 | 0.462 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.224503e-01 | 0.374 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.224503e-01 | 0.374 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.385621e-01 | 0.622 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.115864e-01 | 0.506 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.673735e-01 | 0.435 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.923828e-01 | 0.406 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.623318e-01 | 0.335 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.623318e-01 | 0.335 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.623318e-01 | 0.335 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.623318e-01 | 0.335 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.216362e-01 | 0.375 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.169271e-01 | 0.499 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.169271e-01 | 0.499 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.682936e-01 | 0.571 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.682936e-01 | 0.571 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.337011e-01 | 0.477 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.569846e-01 | 0.340 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.569846e-01 | 0.340 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.569846e-01 | 0.340 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.176469e-01 | 0.286 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.176469e-01 | 0.286 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.176469e-01 | 0.286 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.176469e-01 | 0.286 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.176469e-01 | 0.286 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.176469e-01 | 0.286 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.176469e-01 | 0.286 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.176469e-01 | 0.286 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.176469e-01 | 0.286 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.053956e-01 | 0.515 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.696702e-01 | 0.432 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.180696e-01 | 0.379 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.520599e-01 | 0.345 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.520599e-01 | 0.345 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.190104e-01 | 0.496 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.190104e-01 | 0.496 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.475272e-01 | 0.349 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.475272e-01 | 0.349 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.433241e-01 | 0.353 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.393957e-01 | 0.357 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.907918e-01 | 0.309 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.747246e-01 | 0.324 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.226392e-01 | 0.374 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.627487e-01 | 0.335 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.529586e-01 | 0.344 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.184038e-01 | 0.378 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.360397e-01 | 0.360 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.794425e-01 | 0.319 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.015218e-01 | 0.300 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.114271e-01 | 0.291 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.236910e-01 | 0.281 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.236910e-01 | 0.281 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.236910e-01 | 0.281 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.399538e-01 | 0.268 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.399538e-01 | 0.268 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.399538e-01 | 0.268 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.399538e-01 | 0.268 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.643006e-01 | 0.248 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.643006e-01 | 0.248 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.878255e-01 | 0.312 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.878255e-01 | 0.312 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.742226e-01 | 0.324 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.087750e-01 | 0.293 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.087750e-01 | 0.293 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.946101e-01 | 0.306 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.143953e-01 | 0.289 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.401106e-01 | 0.268 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.330859e-01 | 0.273 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.541697e-01 | 0.256 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.371728e-01 | 0.863 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.171668e-01 | 0.663 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.660180e-01 | 0.575 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.767382e-01 | 0.322 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.767382e-01 | 0.322 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.360525e-01 | 0.866 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.156112e-01 | 0.666 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.949153e-01 | 0.305 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.193918e-01 | 0.496 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.156147e-01 | 0.501 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.053268e-01 | 0.977 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.726871e-01 | 0.763 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.560315e-01 | 0.592 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.135224e-01 | 0.671 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.293335e-01 | 0.482 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.770041e-01 | 0.558 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.188454e-01 | 0.660 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.793076e-01 | 0.746 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.059552e-01 | 0.686 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.159691e-01 | 0.936 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.633521e-01 | 0.334 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.550313e-02 | 1.020 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.520405e-01 | 0.818 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.629743e-01 | 0.580 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.068208e-01 | 0.391 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.064423e-01 | 0.391 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.231077e-01 | 0.281 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.874021e-01 | 0.412 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.688848e-01 | 0.433 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.450305e-02 | 1.025 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.370085e-01 | 0.472 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.600912e-01 | 0.444 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.569846e-01 | 0.340 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.506643e-01 | 0.455 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.433758e-01 | 0.265 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.156378e-01 | 0.381 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.148353e-01 | 0.502 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.032116e-01 | 0.692 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.107702e-01 | 0.676 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.943295e-01 | 0.531 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.395953e-01 | 0.621 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.210817e-01 | 0.655 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.486120e-01 | 0.348 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.111089e-01 | 0.507 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.937595e-01 | 0.405 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.749559e-01 | 0.757 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.881979e-01 | 0.725 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.524912e-01 | 0.817 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.123781e-01 | 0.673 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.475272e-01 | 0.349 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.979800e-01 | 0.400 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.643006e-01 | 0.248 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.184893e-01 | 0.926 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.214333e-01 | 0.375 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.565347e-01 | 0.255 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.421272e-01 | 0.847 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.210817e-01 | 0.655 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.520405e-01 | 0.818 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.333061e-01 | 0.875 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.608401e-01 | 0.584 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.971832e-01 | 0.705 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.186864e-01 | 0.497 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.683856e-01 | 0.329 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.858983e-01 | 0.313 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.698921e-01 | 0.569 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.882406e-01 | 0.725 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.518904e-01 | 0.818 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.860568e-01 | 0.730 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.032116e-01 | 0.692 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.590918e-01 | 0.587 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.854783e-01 | 0.732 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.943295e-01 | 0.531 | 1 | 1 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.685673e-01 | 0.773 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.370085e-01 | 0.472 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.501394e-01 | 0.602 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.138729e-01 | 0.503 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.003771e-01 | 0.522 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.176469e-01 | 0.286 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.186864e-01 | 0.497 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.321986e-01 | 0.364 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.033905e-01 | 0.692 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.587623e-01 | 0.338 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.592609e-01 | 0.798 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.532242e-01 | 0.596 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.596063e-01 | 0.797 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.224503e-01 | 0.374 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.326321e-01 | 0.633 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.747246e-01 | 0.324 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.445316e-01 | 0.612 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.107702e-01 | 0.676 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.596357e-01 | 0.444 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.596357e-01 | 0.444 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.370085e-01 | 0.472 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.370085e-01 | 0.472 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.712661e-02 | 1.013 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.793076e-01 | 0.746 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 3.520859e-01 | 0.453 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.415127e-01 | 0.849 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.206460e-01 | 0.918 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.032633e-01 | 0.692 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.176469e-01 | 0.286 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.643006e-01 | 0.248 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.643006e-01 | 0.248 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.001183e-01 | 0.999 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.865347e-01 | 0.413 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.260766e-01 | 0.487 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.260766e-01 | 0.487 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.501155e-01 | 0.456 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.293335e-01 | 0.482 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.275302e-01 | 0.278 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.624392e-01 | 0.441 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.641025e-01 | 0.785 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.216362e-01 | 0.375 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.176469e-01 | 0.286 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.301323e-01 | 0.886 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.688848e-01 | 0.433 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.907918e-01 | 0.309 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.284330e-01 | 0.277 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.641025e-01 | 0.785 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.377862e-01 | 0.359 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.554611e-01 | 0.808 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.624392e-01 | 0.441 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.624392e-01 | 0.441 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.599760e-01 | 0.444 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.324524e-01 | 0.634 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.445462e-01 | 0.352 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.275302e-01 | 0.278 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.652501e-01 | 0.782 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 9.844053e-02 | 1.007 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.445316e-01 | 0.612 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.445316e-01 | 0.612 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.024954e-01 | 0.519 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.520406e-01 | 0.599 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.943295e-01 | 0.531 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.550192e-01 | 0.593 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.415127e-01 | 0.849 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.214333e-01 | 0.375 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.623318e-01 | 0.335 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.623318e-01 | 0.335 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.176469e-01 | 0.286 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.820365e-01 | 0.317 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.747246e-01 | 0.324 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.236910e-01 | 0.281 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.175783e-01 | 0.286 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.622567e-01 | 0.790 | 1 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.578352e-01 | 0.802 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.683856e-01 | 0.329 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.874021e-01 | 0.412 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.946101e-01 | 0.306 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.705700e-01 | 0.431 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.462711e-01 | 0.461 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.160132e-01 | 0.500 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.446556e-01 | 0.611 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.712217e-01 | 0.766 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.370085e-01 | 0.472 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.860568e-01 | 0.730 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.623318e-01 | 0.335 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.475272e-01 | 0.349 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.747246e-01 | 0.324 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.747246e-01 | 0.324 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.953387e-01 | 0.305 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.112725e-01 | 0.675 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.741821e-01 | 0.562 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.653315e-01 | 0.782 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.241539e-01 | 0.372 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.935905e-01 | 0.532 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.333061e-01 | 0.875 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.168165e-01 | 0.664 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.168165e-01 | 0.664 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.128698e-01 | 0.672 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.156697e-01 | 0.381 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.568735e-01 | 0.340 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.578504e-01 | 0.339 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.533109e-01 | 0.257 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.871303e-01 | 0.728 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.445316e-01 | 0.612 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 2.107702e-01 | 0.676 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.046950e-01 | 0.980 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.679494e-01 | 0.330 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.167802e-01 | 0.499 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.149589e-01 | 0.382 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.770041e-01 | 0.558 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.770041e-01 | 0.558 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.994754e-01 | 0.524 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.370925e-01 | 0.472 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.214333e-01 | 0.375 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.909221e-01 | 0.408 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.840855e-01 | 0.547 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.176469e-01 | 0.286 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.176469e-01 | 0.286 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.576442e-01 | 0.339 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.284615e-01 | 0.484 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.820079e-01 | 0.418 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.865347e-01 | 0.413 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.798268e-01 | 0.745 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.377812e-01 | 0.861 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.685673e-01 | 0.773 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.421427e-01 | 0.466 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.224503e-01 | 0.374 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.010337e-01 | 0.300 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.685673e-01 | 0.773 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.392043e-01 | 0.470 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.520859e-01 | 0.453 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.356985e-01 | 0.361 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.433758e-01 | 0.265 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.433758e-01 | 0.265 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.956819e-01 | 0.708 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.795310e-01 | 0.421 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.952473e-01 | 0.305 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.076224e-01 | 0.968 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.299108e-01 | 0.276 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.583804e-01 | 0.800 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.582395e-01 | 0.801 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.924777e-01 | 0.534 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.874021e-01 | 0.412 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.488319e-01 | 0.604 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.799539e-01 | 0.553 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.920338e-01 | 0.308 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.281317e-01 | 0.484 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.695320e-01 | 0.328 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 4.625675e-01 | 0.335 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.436319e-01 | 0.843 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.019185e-01 | 0.299 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.911889e-01 | 0.719 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.135224e-01 | 0.671 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.392829e-01 | 0.856 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.383154e-01 | 0.623 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.383154e-01 | 0.623 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.517583e-01 | 0.819 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.370085e-01 | 0.472 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.795310e-01 | 0.421 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.520859e-01 | 0.453 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.677785e-01 | 0.330 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.799539e-01 | 0.553 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.194187e-01 | 0.496 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.980364e-01 | 0.400 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.483642e-01 | 0.261 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.677816e-01 | 0.434 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.128698e-01 | 0.672 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.778483e-01 | 0.750 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.149344e-01 | 0.502 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.826374e-01 | 0.316 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.112725e-01 | 0.675 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.441898e-01 | 0.612 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.822111e-01 | 0.739 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.141441e-01 | 0.669 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.149589e-01 | 0.382 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.264448e-01 | 0.645 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.415527e-01 | 0.266 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.383154e-01 | 0.623 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.360740e-01 | 0.866 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.436351e-02 | 1.025 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.436351e-02 | 1.025 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.520859e-01 | 0.453 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.331950e-01 | 0.477 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.445462e-01 | 0.352 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.445462e-01 | 0.352 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.770041e-01 | 0.558 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.854417e-01 | 0.732 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.569846e-01 | 0.340 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.534583e-01 | 0.257 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.598032e-01 | 0.585 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.428297e-01 | 0.615 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.200787e-01 | 0.657 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.321270e-01 | 0.479 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.171388e-01 | 0.499 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.520599e-01 | 0.345 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.478776e-01 | 0.830 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.814346e-01 | 0.551 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.263838e-01 | 0.279 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.501394e-01 | 0.602 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.727152e-01 | 0.763 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.445316e-01 | 0.612 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.445316e-01 | 0.612 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.770243e-01 | 0.424 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.107702e-01 | 0.676 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.520406e-01 | 0.599 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.520406e-01 | 0.599 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.141441e-01 | 0.669 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.141441e-01 | 0.669 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.841263e-01 | 0.735 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.596063e-01 | 0.797 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.943295e-01 | 0.531 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 3.596357e-01 | 0.444 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.596357e-01 | 0.444 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.679494e-01 | 0.330 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.679494e-01 | 0.330 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.564153e-01 | 0.591 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.988528e-01 | 0.525 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.795310e-01 | 0.421 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.874021e-01 | 0.412 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.874021e-01 | 0.412 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.456082e-01 | 0.263 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.224503e-01 | 0.374 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.138729e-01 | 0.503 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.178953e-01 | 0.498 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.445462e-01 | 0.352 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.484384e-01 | 0.828 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.428297e-01 | 0.615 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.305455e-01 | 0.275 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.232212e-01 | 0.651 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.646872e-01 | 0.438 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.511254e-01 | 0.259 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.356985e-01 | 0.361 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.287822e-01 | 0.483 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.352301e-01 | 0.869 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.344303e-01 | 0.272 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.520859e-01 | 0.453 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.391749e-01 | 0.856 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.817938e-01 | 0.550 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.424138e-01 | 0.465 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.458814e-01 | 0.263 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.450305e-02 | 1.025 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.518904e-01 | 0.818 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.223407e-01 | 0.492 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.643006e-01 | 0.248 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.568796e-01 | 0.804 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.696702e-01 | 0.432 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.462711e-01 | 0.461 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.679264e-01 | 0.775 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.988528e-01 | 0.525 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.193918e-01 | 0.496 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.520599e-01 | 0.345 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.071782e-01 | 0.970 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.692129e-01 | 0.570 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.677816e-01 | 0.434 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.844053e-02 | 1.007 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.240016e-01 | 0.907 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.024954e-01 | 0.519 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.784167e-01 | 0.749 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.935660e-01 | 0.713 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.677785e-01 | 0.330 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.623318e-01 | 0.335 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.623318e-01 | 0.335 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.623318e-01 | 0.335 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.520599e-01 | 0.345 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.019185e-01 | 0.299 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.555328e-01 | 0.255 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.117153e-01 | 0.291 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.383154e-01 | 0.623 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.960892e-01 | 0.708 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.107702e-01 | 0.676 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.019185e-01 | 0.299 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.216362e-01 | 0.375 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.555328e-01 | 0.255 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.263838e-01 | 0.279 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.213041e-01 | 0.916 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.821927e-01 | 0.739 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.474624e-01 | 0.606 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.679494e-01 | 0.330 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.370085e-01 | 0.472 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.456082e-01 | 0.263 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.820365e-01 | 0.317 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.763982e-01 | 0.424 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.736121e-01 | 0.325 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.794425e-01 | 0.319 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.399538e-01 | 0.268 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.143953e-01 | 0.289 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.383315e-01 | 0.859 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.821927e-01 | 0.739 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.381340e-01 | 0.471 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.314731e-01 | 0.480 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.015218e-01 | 0.300 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.456082e-01 | 0.263 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.401106e-01 | 0.268 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.596357e-01 | 0.444 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.679494e-01 | 0.330 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.677785e-01 | 0.330 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.456082e-01 | 0.263 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.878255e-01 | 0.312 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.628500e-01 | 0.580 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.231077e-01 | 0.281 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.167802e-01 | 0.499 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.907918e-01 | 0.309 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.643006e-01 | 0.248 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.643006e-01 | 0.248 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.370085e-01 | 0.472 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.841263e-01 | 0.735 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.677785e-01 | 0.330 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.456082e-01 | 0.263 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.643006e-01 | 0.248 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.916242e-01 | 0.535 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.824196e-01 | 0.739 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.399538e-01 | 0.268 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.679837e-01 | 0.246 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.679837e-01 | 0.246 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.682541e-01 | 0.245 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.682541e-01 | 0.245 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.762598e-01 | 0.239 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.762598e-01 | 0.239 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.762598e-01 | 0.239 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.762598e-01 | 0.239 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.762598e-01 | 0.239 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.762598e-01 | 0.239 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.762598e-01 | 0.239 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.785792e-01 | 0.238 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.785792e-01 | 0.238 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.785792e-01 | 0.238 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.785792e-01 | 0.238 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.803081e-01 | 0.236 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.823104e-01 | 0.235 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.843864e-01 | 0.233 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.861970e-01 | 0.232 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.861970e-01 | 0.232 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.861970e-01 | 0.232 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.903867e-01 | 0.229 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.907550e-01 | 0.229 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.926083e-01 | 0.227 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.947110e-01 | 0.226 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.949599e-01 | 0.226 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.949599e-01 | 0.226 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.949599e-01 | 0.226 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.949599e-01 | 0.226 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.949599e-01 | 0.226 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.956025e-01 | 0.225 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.963527e-01 | 0.224 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.028988e-01 | 0.220 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.040781e-01 | 0.219 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.076155e-01 | 0.216 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.076155e-01 | 0.216 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.076155e-01 | 0.216 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 6.076155e-01 | 0.216 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.076155e-01 | 0.216 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 6.076155e-01 | 0.216 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.076155e-01 | 0.216 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.076155e-01 | 0.216 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.107124e-01 | 0.214 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.107124e-01 | 0.214 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 6.119356e-01 | 0.213 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.119356e-01 | 0.213 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 6.119356e-01 | 0.213 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 6.119356e-01 | 0.213 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.119356e-01 | 0.213 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.119356e-01 | 0.213 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.119356e-01 | 0.213 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.119356e-01 | 0.213 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.119356e-01 | 0.213 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.119356e-01 | 0.213 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.119356e-01 | 0.213 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.119356e-01 | 0.213 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.125330e-01 | 0.213 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.155908e-01 | 0.211 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.155908e-01 | 0.211 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.155908e-01 | 0.211 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.155908e-01 | 0.211 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.160407e-01 | 0.210 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.176784e-01 | 0.209 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.179512e-01 | 0.209 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.204968e-01 | 0.207 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.209690e-01 | 0.207 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.209690e-01 | 0.207 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.234038e-01 | 0.205 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.240268e-01 | 0.205 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.242420e-01 | 0.205 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.242420e-01 | 0.205 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.264352e-01 | 0.203 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.294393e-01 | 0.201 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.302116e-01 | 0.201 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.351700e-01 | 0.197 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.383551e-01 | 0.195 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.432341e-01 | 0.192 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.432341e-01 | 0.192 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.432341e-01 | 0.192 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.432341e-01 | 0.192 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.436463e-01 | 0.191 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.436463e-01 | 0.191 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.436463e-01 | 0.191 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.436463e-01 | 0.191 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.436463e-01 | 0.191 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.436463e-01 | 0.191 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.459563e-01 | 0.190 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.461741e-01 | 0.190 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.475723e-01 | 0.189 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.475723e-01 | 0.189 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 6.475723e-01 | 0.189 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.475723e-01 | 0.189 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.475723e-01 | 0.189 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 6.475723e-01 | 0.189 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.475723e-01 | 0.189 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.475723e-01 | 0.189 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.475723e-01 | 0.189 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.491440e-01 | 0.188 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.491440e-01 | 0.188 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.527624e-01 | 0.185 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.566429e-01 | 0.183 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.644467e-01 | 0.178 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.644467e-01 | 0.178 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.685844e-01 | 0.175 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.685844e-01 | 0.175 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.685844e-01 | 0.175 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.685844e-01 | 0.175 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.685844e-01 | 0.175 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.685844e-01 | 0.175 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.685844e-01 | 0.175 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.685844e-01 | 0.175 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.685844e-01 | 0.175 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.685844e-01 | 0.175 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.685844e-01 | 0.175 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.685844e-01 | 0.175 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.698810e-01 | 0.174 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.698810e-01 | 0.174 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.700105e-01 | 0.174 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.703181e-01 | 0.174 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.703181e-01 | 0.174 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.703886e-01 | 0.174 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.709908e-01 | 0.173 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.709908e-01 | 0.173 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.737867e-01 | 0.171 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.737867e-01 | 0.171 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.737867e-01 | 0.171 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.737867e-01 | 0.171 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.737867e-01 | 0.171 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.782373e-01 | 0.169 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.842282e-01 | 0.165 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.842282e-01 | 0.165 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.842282e-01 | 0.165 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.842282e-01 | 0.165 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.842282e-01 | 0.165 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.842282e-01 | 0.165 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.842282e-01 | 0.165 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.842282e-01 | 0.165 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.842282e-01 | 0.165 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.842282e-01 | 0.165 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.843008e-01 | 0.165 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.874484e-01 | 0.163 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.906235e-01 | 0.161 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.919497e-01 | 0.160 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.927156e-01 | 0.159 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.927156e-01 | 0.159 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.927156e-01 | 0.159 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.953957e-01 | 0.158 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.955806e-01 | 0.158 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.955806e-01 | 0.158 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.955806e-01 | 0.158 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.955806e-01 | 0.158 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.969732e-01 | 0.157 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.000120e-01 | 0.155 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.023651e-01 | 0.153 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.023651e-01 | 0.153 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.023651e-01 | 0.153 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.023651e-01 | 0.153 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.111059e-01 | 0.148 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.111059e-01 | 0.148 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.111059e-01 | 0.148 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.120038e-01 | 0.148 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.120038e-01 | 0.148 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.120038e-01 | 0.148 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.138037e-01 | 0.146 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.144440e-01 | 0.146 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.169666e-01 | 0.145 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.169666e-01 | 0.145 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.169666e-01 | 0.145 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.169666e-01 | 0.145 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.169666e-01 | 0.145 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.169666e-01 | 0.145 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.169666e-01 | 0.145 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.169666e-01 | 0.145 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 7.169666e-01 | 0.145 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 7.169666e-01 | 0.145 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.169666e-01 | 0.145 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.169666e-01 | 0.145 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 7.169666e-01 | 0.145 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.169666e-01 | 0.145 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.169666e-01 | 0.145 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.169666e-01 | 0.145 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.169666e-01 | 0.145 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.169666e-01 | 0.145 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.169666e-01 | 0.145 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.169666e-01 | 0.145 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 7.169666e-01 | 0.145 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 7.169666e-01 | 0.145 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.169666e-01 | 0.145 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.176955e-01 | 0.144 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.176955e-01 | 0.144 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.176955e-01 | 0.144 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.176955e-01 | 0.144 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.176955e-01 | 0.144 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.176955e-01 | 0.144 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.176955e-01 | 0.144 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.176955e-01 | 0.144 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.176955e-01 | 0.144 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.176955e-01 | 0.144 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.176955e-01 | 0.144 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.176955e-01 | 0.144 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.182735e-01 | 0.144 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.194256e-01 | 0.143 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.194256e-01 | 0.143 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.194256e-01 | 0.143 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.194256e-01 | 0.143 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.194256e-01 | 0.143 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.194256e-01 | 0.143 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.267922e-01 | 0.139 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.267922e-01 | 0.139 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.279457e-01 | 0.138 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.279457e-01 | 0.138 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.280748e-01 | 0.138 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.289910e-01 | 0.137 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.293436e-01 | 0.137 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.313039e-01 | 0.136 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.350609e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.351779e-01 | 0.134 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.370063e-01 | 0.133 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.370063e-01 | 0.133 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.438888e-01 | 0.128 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.440008e-01 | 0.128 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.442669e-01 | 0.128 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.461486e-01 | 0.127 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.461486e-01 | 0.127 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.461486e-01 | 0.127 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.481239e-01 | 0.126 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.481239e-01 | 0.126 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.481239e-01 | 0.126 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.481239e-01 | 0.126 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.481239e-01 | 0.126 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.481239e-01 | 0.126 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.481239e-01 | 0.126 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.481239e-01 | 0.126 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.481239e-01 | 0.126 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.481239e-01 | 0.126 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.481239e-01 | 0.126 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.481239e-01 | 0.126 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.481239e-01 | 0.126 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.481239e-01 | 0.126 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.481239e-01 | 0.126 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.493658e-01 | 0.125 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.493658e-01 | 0.125 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.517988e-01 | 0.124 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.537076e-01 | 0.123 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.537076e-01 | 0.123 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.537076e-01 | 0.123 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.537076e-01 | 0.123 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.537076e-01 | 0.123 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.545702e-01 | 0.122 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.545702e-01 | 0.122 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.582879e-01 | 0.120 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.582879e-01 | 0.120 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.582879e-01 | 0.120 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.582879e-01 | 0.120 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.582879e-01 | 0.120 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.582879e-01 | 0.120 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.582879e-01 | 0.120 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.582879e-01 | 0.120 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.582879e-01 | 0.120 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.582879e-01 | 0.120 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.582879e-01 | 0.120 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.599205e-01 | 0.119 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.666750e-01 | 0.115 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.694145e-01 | 0.114 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.699649e-01 | 0.114 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.722536e-01 | 0.112 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.729840e-01 | 0.112 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.729840e-01 | 0.112 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.729840e-01 | 0.112 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.729840e-01 | 0.112 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.738378e-01 | 0.111 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.738378e-01 | 0.111 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.738378e-01 | 0.111 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.746045e-01 | 0.111 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.746045e-01 | 0.111 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.746045e-01 | 0.111 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.756871e-01 | 0.110 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.756871e-01 | 0.110 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.756871e-01 | 0.110 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.756871e-01 | 0.110 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.756871e-01 | 0.110 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.756871e-01 | 0.110 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.756871e-01 | 0.110 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.756871e-01 | 0.110 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.756871e-01 | 0.110 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.756871e-01 | 0.110 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.765754e-01 | 0.110 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.765754e-01 | 0.110 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.765754e-01 | 0.110 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.804341e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.825850e-01 | 0.106 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.825850e-01 | 0.106 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.825850e-01 | 0.106 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.830800e-01 | 0.106 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.830800e-01 | 0.106 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.830800e-01 | 0.106 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.830800e-01 | 0.106 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.903212e-01 | 0.102 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.918261e-01 | 0.101 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.928708e-01 | 0.101 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.935786e-01 | 0.100 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.935786e-01 | 0.100 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.935786e-01 | 0.100 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.935786e-01 | 0.100 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.935786e-01 | 0.100 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.935786e-01 | 0.100 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.935786e-01 | 0.100 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.935786e-01 | 0.100 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.935786e-01 | 0.100 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.935786e-01 | 0.100 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.935786e-01 | 0.100 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.935786e-01 | 0.100 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.976672e-01 | 0.098 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.976672e-01 | 0.098 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.985949e-01 | 0.098 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.998821e-01 | 0.097 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.005732e-01 | 0.097 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.005732e-01 | 0.097 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.005732e-01 | 0.097 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.005732e-01 | 0.097 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.005732e-01 | 0.097 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.005732e-01 | 0.097 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.005732e-01 | 0.097 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.005732e-01 | 0.097 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.005732e-01 | 0.097 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.005732e-01 | 0.097 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.005732e-01 | 0.097 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.005732e-01 | 0.097 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.009445e-01 | 0.096 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.009445e-01 | 0.096 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.059407e-01 | 0.094 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.066068e-01 | 0.093 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.069143e-01 | 0.093 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.131413e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.132379e-01 | 0.090 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.149941e-01 | 0.089 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.150219e-01 | 0.089 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.150588e-01 | 0.089 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.170655e-01 | 0.088 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.170655e-01 | 0.088 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.170655e-01 | 0.088 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.195883e-01 | 0.086 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.218705e-01 | 0.085 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.218705e-01 | 0.085 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.218705e-01 | 0.085 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.229761e-01 | 0.085 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.229761e-01 | 0.085 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.229761e-01 | 0.085 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.229761e-01 | 0.085 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.229761e-01 | 0.085 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.229761e-01 | 0.085 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.229761e-01 | 0.085 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.229761e-01 | 0.085 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.235354e-01 | 0.084 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.237185e-01 | 0.084 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.237185e-01 | 0.084 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 8.237185e-01 | 0.084 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.237185e-01 | 0.084 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.237185e-01 | 0.084 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.237185e-01 | 0.084 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.237185e-01 | 0.084 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.237185e-01 | 0.084 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.237185e-01 | 0.084 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.237185e-01 | 0.084 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.237185e-01 | 0.084 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.237185e-01 | 0.084 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.264812e-01 | 0.083 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.270309e-01 | 0.082 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.272331e-01 | 0.082 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.327876e-01 | 0.079 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.338835e-01 | 0.079 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.338835e-01 | 0.079 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.338835e-01 | 0.079 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.348588e-01 | 0.078 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.348588e-01 | 0.078 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.348588e-01 | 0.078 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.348588e-01 | 0.078 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.387742e-01 | 0.076 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.387742e-01 | 0.076 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.399986e-01 | 0.076 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.399986e-01 | 0.076 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.399986e-01 | 0.076 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.399986e-01 | 0.076 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.399986e-01 | 0.076 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.429745e-01 | 0.074 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.430903e-01 | 0.074 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.430903e-01 | 0.074 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.430903e-01 | 0.074 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.430903e-01 | 0.074 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.430903e-01 | 0.074 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.430903e-01 | 0.074 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.430903e-01 | 0.074 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.430903e-01 | 0.074 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.436764e-01 | 0.074 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.485686e-01 | 0.071 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.489480e-01 | 0.071 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.494591e-01 | 0.071 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.494591e-01 | 0.071 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.494591e-01 | 0.071 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.494591e-01 | 0.071 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.494591e-01 | 0.071 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 8.494591e-01 | 0.071 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.494591e-01 | 0.071 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.494704e-01 | 0.071 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.494704e-01 | 0.071 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.494704e-01 | 0.071 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.494704e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.507340e-01 | 0.070 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.511334e-01 | 0.070 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.511396e-01 | 0.070 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.511396e-01 | 0.070 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.511396e-01 | 0.070 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.511396e-01 | 0.070 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.511396e-01 | 0.070 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.511396e-01 | 0.070 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.521680e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.540882e-01 | 0.068 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.558346e-01 | 0.068 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.611065e-01 | 0.065 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.611065e-01 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.618828e-01 | 0.065 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.618828e-01 | 0.065 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.618828e-01 | 0.065 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.618828e-01 | 0.065 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.621398e-01 | 0.064 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.627664e-01 | 0.064 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.635684e-01 | 0.064 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.635684e-01 | 0.064 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.660021e-01 | 0.062 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.660021e-01 | 0.062 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.660021e-01 | 0.062 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.660021e-01 | 0.062 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.660021e-01 | 0.062 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.680444e-01 | 0.061 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.697662e-01 | 0.061 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.703430e-01 | 0.060 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.714423e-01 | 0.060 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.714423e-01 | 0.060 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.714423e-01 | 0.060 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.714423e-01 | 0.060 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.714423e-01 | 0.060 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.714423e-01 | 0.060 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.714423e-01 | 0.060 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.714423e-01 | 0.060 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.714423e-01 | 0.060 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.714423e-01 | 0.060 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.714423e-01 | 0.060 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.714423e-01 | 0.060 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.734241e-01 | 0.059 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.734241e-01 | 0.059 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.734241e-01 | 0.059 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.734241e-01 | 0.059 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.734241e-01 | 0.059 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.734241e-01 | 0.059 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.742302e-01 | 0.058 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.742302e-01 | 0.058 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.746559e-01 | 0.058 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.746559e-01 | 0.058 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.746559e-01 | 0.058 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.772083e-01 | 0.057 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.772083e-01 | 0.057 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.772083e-01 | 0.057 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.772083e-01 | 0.057 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.781357e-01 | 0.056 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.789430e-01 | 0.056 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.795405e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.795405e-01 | 0.056 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.795405e-01 | 0.056 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.795405e-01 | 0.056 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.795405e-01 | 0.056 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.795405e-01 | 0.056 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.807977e-01 | 0.055 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.841363e-01 | 0.053 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.854879e-01 | 0.053 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.857513e-01 | 0.053 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.861768e-01 | 0.052 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.861768e-01 | 0.052 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.861768e-01 | 0.052 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.902165e-01 | 0.051 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.902165e-01 | 0.051 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.902165e-01 | 0.051 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.902165e-01 | 0.051 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.902165e-01 | 0.051 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.902165e-01 | 0.051 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.910310e-01 | 0.050 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.915706e-01 | 0.050 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.915706e-01 | 0.050 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.915706e-01 | 0.050 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.918479e-01 | 0.050 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.918479e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.918479e-01 | 0.050 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.918479e-01 | 0.050 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.918479e-01 | 0.050 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.934629e-01 | 0.049 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.940620e-01 | 0.049 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.940620e-01 | 0.049 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.940620e-01 | 0.049 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.940620e-01 | 0.049 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.967621e-01 | 0.047 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.967621e-01 | 0.047 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.991167e-01 | 0.046 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.021030e-01 | 0.045 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.022864e-01 | 0.045 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.032439e-01 | 0.044 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.043580e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.043580e-01 | 0.044 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.043580e-01 | 0.044 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.043580e-01 | 0.044 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.049538e-01 | 0.043 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.049538e-01 | 0.043 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.056503e-01 | 0.043 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 9.062498e-01 | 0.043 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 9.062498e-01 | 0.043 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 9.062498e-01 | 0.043 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.062498e-01 | 0.043 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.062498e-01 | 0.043 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 9.062498e-01 | 0.043 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 9.062498e-01 | 0.043 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.064708e-01 | 0.043 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.064708e-01 | 0.043 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.065700e-01 | 0.043 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.098639e-01 | 0.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.098639e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.098639e-01 | 0.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.098639e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.098639e-01 | 0.041 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.116931e-01 | 0.040 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.117243e-01 | 0.040 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.131288e-01 | 0.039 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.131288e-01 | 0.039 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.133136e-01 | 0.039 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.153605e-01 | 0.038 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.153605e-01 | 0.038 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.153605e-01 | 0.038 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.157240e-01 | 0.038 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.157240e-01 | 0.038 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.157240e-01 | 0.038 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.157240e-01 | 0.038 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.157240e-01 | 0.038 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.175825e-01 | 0.037 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.179187e-01 | 0.037 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.195449e-01 | 0.036 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.195449e-01 | 0.036 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.195449e-01 | 0.036 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.199423e-01 | 0.036 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.199423e-01 | 0.036 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.199423e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.222737e-01 | 0.035 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.222737e-01 | 0.035 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.227364e-01 | 0.035 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.234136e-01 | 0.035 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.234874e-01 | 0.035 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.234874e-01 | 0.035 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.244885e-01 | 0.034 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.245778e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.258110e-01 | 0.033 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.258110e-01 | 0.033 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.258110e-01 | 0.033 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.258110e-01 | 0.033 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.267464e-01 | 0.033 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.292695e-01 | 0.032 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.305290e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.305290e-01 | 0.031 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.305290e-01 | 0.031 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.308807e-01 | 0.031 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.309055e-01 | 0.031 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.316357e-01 | 0.031 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.316357e-01 | 0.031 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.316357e-01 | 0.031 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.316357e-01 | 0.031 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.316357e-01 | 0.031 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.316357e-01 | 0.031 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.316357e-01 | 0.031 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.316357e-01 | 0.031 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.316357e-01 | 0.031 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.322222e-01 | 0.030 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.322222e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.347211e-01 | 0.029 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.347327e-01 | 0.029 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.347501e-01 | 0.029 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.347501e-01 | 0.029 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.347501e-01 | 0.029 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.347501e-01 | 0.029 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.347501e-01 | 0.029 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.367897e-01 | 0.028 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.369452e-01 | 0.028 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.374799e-01 | 0.028 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.376669e-01 | 0.028 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.376669e-01 | 0.028 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.379702e-01 | 0.028 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.406086e-01 | 0.027 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.412753e-01 | 0.026 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.416217e-01 | 0.026 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.416217e-01 | 0.026 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.416217e-01 | 0.026 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.416217e-01 | 0.026 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.416217e-01 | 0.026 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.416217e-01 | 0.026 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.416217e-01 | 0.026 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.416217e-01 | 0.026 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.416217e-01 | 0.026 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.416217e-01 | 0.026 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.426613e-01 | 0.026 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.426613e-01 | 0.026 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.426613e-01 | 0.026 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.438210e-01 | 0.025 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.442186e-01 | 0.025 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.446679e-01 | 0.025 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.446702e-01 | 0.025 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.450271e-01 | 0.025 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.472758e-01 | 0.024 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.472758e-01 | 0.024 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.483978e-01 | 0.023 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.489290e-01 | 0.023 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.494150e-01 | 0.023 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.494150e-01 | 0.023 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.496542e-01 | 0.022 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.501495e-01 | 0.022 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.501495e-01 | 0.022 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.501495e-01 | 0.022 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.501495e-01 | 0.022 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.501495e-01 | 0.022 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.506881e-01 | 0.022 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.506881e-01 | 0.022 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.506881e-01 | 0.022 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.521224e-01 | 0.021 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.531081e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.544932e-01 | 0.020 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.548088e-01 | 0.020 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.548088e-01 | 0.020 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.560925e-01 | 0.020 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.560925e-01 | 0.020 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.560925e-01 | 0.020 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.560925e-01 | 0.020 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.560925e-01 | 0.020 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.560925e-01 | 0.020 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.564658e-01 | 0.019 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.571940e-01 | 0.019 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.574320e-01 | 0.019 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.574320e-01 | 0.019 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.574320e-01 | 0.019 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.574320e-01 | 0.019 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.574320e-01 | 0.019 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.574320e-01 | 0.019 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.574320e-01 | 0.019 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.574320e-01 | 0.019 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.574320e-01 | 0.019 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.574320e-01 | 0.019 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.574320e-01 | 0.019 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.584997e-01 | 0.018 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.590791e-01 | 0.018 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.590975e-01 | 0.018 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.600896e-01 | 0.018 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.600896e-01 | 0.018 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.609380e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.609380e-01 | 0.017 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.609380e-01 | 0.017 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.612731e-01 | 0.017 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.612731e-01 | 0.017 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.624569e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.636510e-01 | 0.016 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.636510e-01 | 0.016 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.636510e-01 | 0.016 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.636510e-01 | 0.016 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.636510e-01 | 0.016 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.636858e-01 | 0.016 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.646320e-01 | 0.016 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.649745e-01 | 0.015 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.650187e-01 | 0.015 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.650187e-01 | 0.015 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.652773e-01 | 0.015 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.652773e-01 | 0.015 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.660704e-01 | 0.015 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.670390e-01 | 0.015 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.670390e-01 | 0.015 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.689617e-01 | 0.014 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.689617e-01 | 0.014 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.689617e-01 | 0.014 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.689617e-01 | 0.014 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.689617e-01 | 0.014 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.689617e-01 | 0.014 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.689617e-01 | 0.014 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.689617e-01 | 0.014 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.689617e-01 | 0.014 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.691590e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.691590e-01 | 0.014 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.696867e-01 | 0.013 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.701971e-01 | 0.013 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.702929e-01 | 0.013 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.702929e-01 | 0.013 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.715868e-01 | 0.013 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.717072e-01 | 0.012 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.726277e-01 | 0.012 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.727105e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.732769e-01 | 0.012 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.732769e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.733756e-01 | 0.012 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.734968e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.734968e-01 | 0.012 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.734968e-01 | 0.012 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.734968e-01 | 0.012 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.734968e-01 | 0.012 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.734968e-01 | 0.012 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.734968e-01 | 0.012 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.734968e-01 | 0.012 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.734968e-01 | 0.012 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.735234e-01 | 0.012 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.740061e-01 | 0.011 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.747073e-01 | 0.011 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.749938e-01 | 0.011 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.757241e-01 | 0.011 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.772687e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.773694e-01 | 0.010 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.784854e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.784854e-01 | 0.009 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.784854e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.793485e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.798884e-01 | 0.009 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.801331e-01 | 0.009 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.801331e-01 | 0.009 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.803784e-01 | 0.009 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.806764e-01 | 0.008 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.806764e-01 | 0.008 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.806764e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.806764e-01 | 0.008 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.806764e-01 | 0.008 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.809457e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.810723e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.817083e-01 | 0.008 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.820180e-01 | 0.008 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.826460e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.831358e-01 | 0.007 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.833870e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.833870e-01 | 0.007 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.835003e-01 | 0.007 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.835003e-01 | 0.007 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.835003e-01 | 0.007 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.836535e-01 | 0.007 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.838269e-01 | 0.007 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.842137e-01 | 0.007 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.848489e-01 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.848831e-01 | 0.007 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.850837e-01 | 0.007 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.854635e-01 | 0.006 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.854635e-01 | 0.006 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.859117e-01 | 0.006 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.859117e-01 | 0.006 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.859117e-01 | 0.006 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.859117e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.865135e-01 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.867787e-01 | 0.006 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.879707e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.883518e-01 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.884682e-01 | 0.005 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.884682e-01 | 0.005 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.884682e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.892859e-01 | 0.005 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.897290e-01 | 0.004 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.897290e-01 | 0.004 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.897290e-01 | 0.004 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.897290e-01 | 0.004 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.897290e-01 | 0.004 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.900288e-01 | 0.004 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.900288e-01 | 0.004 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.904590e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.906227e-01 | 0.004 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.906836e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.907722e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.907758e-01 | 0.004 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.912303e-01 | 0.004 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.912303e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.912453e-01 | 0.004 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.923685e-01 | 0.003 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.923685e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.923685e-01 | 0.003 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.925122e-01 | 0.003 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.925122e-01 | 0.003 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.925122e-01 | 0.003 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.925122e-01 | 0.003 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.925122e-01 | 0.003 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.925122e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.927120e-01 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.929153e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.929153e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.929153e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.932857e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.934424e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.934724e-01 | 0.003 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.936069e-01 | 0.003 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.936069e-01 | 0.003 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.936069e-01 | 0.003 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.937841e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.942140e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.942165e-01 | 0.003 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.942165e-01 | 0.003 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.942541e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.945415e-01 | 0.002 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.945415e-01 | 0.002 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.945415e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.945415e-01 | 0.002 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.945415e-01 | 0.002 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.945415e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.946997e-01 | 0.002 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.949681e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.949681e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.949681e-01 | 0.002 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.951822e-01 | 0.002 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.953396e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.955007e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.956235e-01 | 0.002 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.956538e-01 | 0.002 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.957615e-01 | 0.002 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.960210e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.960210e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.965583e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.966028e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.966929e-01 | 0.001 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.969308e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.970961e-01 | 0.001 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.970996e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.974287e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.975042e-01 | 0.001 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.975626e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.975626e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.977243e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.978859e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.981188e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.981662e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.982916e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.983674e-01 | 0.001 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.983674e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.983753e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.984263e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.984263e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.984591e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.984591e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.985020e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.985020e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.985020e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.985836e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.986095e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.986845e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.986845e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.986845e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.986845e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.986869e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.987715e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.987877e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.988769e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.989158e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989347e-01 | 0.000 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.990178e-01 | 0.000 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.990412e-01 | 0.000 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.990412e-01 | 0.000 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.990412e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.990527e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990765e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.991223e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.991545e-01 | 0.000 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.991815e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.991821e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.993012e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.993065e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.993216e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.993437e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.993781e-01 | 0.000 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.994035e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994086e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.994574e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.995653e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.995653e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.996048e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.996099e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.996099e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996547e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.996547e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.996631e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.996832e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.997296e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.997296e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.997296e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.997691e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998035e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998173e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998365e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.998564e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.998667e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998688e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998688e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998838e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998912e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.998954e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999002e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999087e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999117e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.999164e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.999170e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999211e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999436e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999475e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999492e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999595e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999621e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.999644e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999668e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999748e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999785e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999790e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999797e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999817e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999819e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999843e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999866e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999870e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999886e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999886e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999900e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999903e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999928e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999929e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999942e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999946e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999952e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999953e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999956e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999963e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999968e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999973e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999973e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999973e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999977e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999979e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999990e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999993e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999995e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Nervous system development | R-HSA-9675108 | 1.442180e-13 | 12.841 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.279288e-13 | 12.642 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.529399e-13 | 12.452 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.949285e-12 | 11.403 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.722356e-12 | 11.429 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.256428e-11 | 10.647 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.874368e-11 | 10.231 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.351453e-10 | 9.629 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.678288e-10 | 9.572 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.387462e-10 | 9.269 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.550732e-09 | 8.593 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.072537e-09 | 8.513 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.892513e-09 | 8.310 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.428012e-08 | 7.845 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.990639e-08 | 7.701 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.156453e-08 | 7.666 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.705649e-08 | 7.431 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.595597e-08 | 7.338 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.019813e-08 | 7.096 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.734087e-08 | 7.112 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.084070e-08 | 7.092 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.014844e-08 | 7.045 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.071251e-07 | 6.970 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.941522e-07 | 6.531 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.123004e-07 | 6.505 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.144149e-07 | 6.383 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.472221e-07 | 6.349 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.784322e-07 | 6.320 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.814534e-07 | 6.235 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.127429e-07 | 6.147 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.127429e-07 | 6.147 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.127429e-07 | 6.147 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.127429e-07 | 6.147 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.198678e-07 | 6.143 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.069045e-07 | 6.042 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.452146e-07 | 6.024 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.046733e-06 | 5.980 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.149433e-06 | 5.940 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.550493e-06 | 5.810 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.682454e-06 | 5.774 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.922870e-06 | 5.716 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.988462e-06 | 5.701 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.972931e-06 | 5.705 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.330086e-06 | 5.633 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.267717e-06 | 5.644 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.435684e-06 | 5.613 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.505422e-06 | 5.601 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.701182e-06 | 5.568 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.894669e-06 | 5.538 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.152915e-06 | 5.501 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.487450e-06 | 5.457 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.711686e-06 | 5.430 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.771422e-06 | 5.423 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.359183e-06 | 5.361 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.888084e-06 | 5.311 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.221167e-06 | 5.282 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.606157e-06 | 5.251 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.022143e-06 | 5.220 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.348912e-06 | 5.197 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.551610e-06 | 5.122 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.399264e-06 | 5.076 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.904754e-06 | 5.050 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.467365e-06 | 5.024 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.467365e-06 | 5.024 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.036598e-05 | 4.984 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.136708e-05 | 4.944 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.241650e-05 | 4.906 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.297869e-05 | 4.887 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.329158e-05 | 4.876 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.925960e-05 | 4.715 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.180183e-05 | 4.662 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.402602e-05 | 4.619 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.451648e-05 | 4.611 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.496863e-05 | 4.603 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.723509e-05 | 4.565 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.688350e-05 | 4.571 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.761630e-05 | 4.559 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.236376e-05 | 4.490 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.671467e-05 | 4.435 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.565225e-05 | 4.448 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.789215e-05 | 4.421 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.937247e-05 | 4.405 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.785834e-05 | 4.320 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.000774e-05 | 4.301 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.696277e-05 | 4.244 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.696277e-05 | 4.244 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.406126e-05 | 4.193 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.066730e-05 | 4.151 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.632638e-05 | 4.117 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.262347e-05 | 4.083 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.904642e-05 | 4.050 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.560311e-05 | 4.068 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.904642e-05 | 4.050 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.523236e-05 | 4.069 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.904642e-05 | 4.050 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.081072e-04 | 3.966 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.123635e-04 | 3.949 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.173995e-04 | 3.930 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.199154e-04 | 3.921 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.136273e-04 | 3.945 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.207348e-04 | 3.918 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.230352e-04 | 3.910 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.261755e-04 | 3.899 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.269825e-04 | 3.896 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.363707e-04 | 3.865 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.367296e-04 | 3.864 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.363707e-04 | 3.865 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.455132e-04 | 3.837 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.483735e-04 | 3.829 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.512551e-04 | 3.820 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.512551e-04 | 3.820 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.530664e-04 | 3.815 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.795056e-04 | 3.746 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.911980e-04 | 3.719 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.129864e-04 | 3.672 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.072534e-04 | 3.683 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.302316e-04 | 3.638 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.445275e-04 | 3.612 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.458612e-04 | 3.609 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.502405e-04 | 3.602 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.502405e-04 | 3.602 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.553911e-04 | 3.593 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.556133e-04 | 3.592 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.860020e-04 | 3.544 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.273169e-04 | 3.485 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.292655e-04 | 3.482 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.608475e-04 | 3.443 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.683115e-04 | 3.434 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.729374e-04 | 3.428 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.053070e-04 | 3.392 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.305767e-04 | 3.366 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.305767e-04 | 3.366 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.362844e-04 | 3.360 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.366114e-04 | 3.360 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.736687e-04 | 3.325 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.672424e-04 | 3.330 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.675187e-04 | 3.330 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.928140e-04 | 3.307 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.944563e-04 | 3.306 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.089313e-04 | 3.293 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.180260e-04 | 3.286 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.486015e-04 | 3.261 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.542118e-04 | 3.256 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.635714e-04 | 3.249 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.797173e-04 | 3.237 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.845556e-04 | 3.233 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.002483e-04 | 3.222 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.430323e-04 | 3.192 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.430323e-04 | 3.192 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.678229e-04 | 3.175 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.795590e-04 | 3.168 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.812896e-04 | 3.167 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.842398e-04 | 3.165 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.135717e-04 | 3.147 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.320300e-04 | 3.135 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.320300e-04 | 3.135 | 1 | 1 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.713534e-04 | 3.113 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.888749e-04 | 3.103 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.016950e-04 | 3.096 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.057402e-04 | 3.094 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.057402e-04 | 3.094 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.232672e-04 | 3.084 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.232672e-04 | 3.084 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.882945e-04 | 3.051 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.388906e-04 | 3.027 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.388906e-04 | 3.027 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.588146e-04 | 3.018 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.605222e-04 | 3.017 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.737224e-04 | 3.012 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.737224e-04 | 3.012 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.737224e-04 | 3.012 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.965827e-04 | 3.001 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.000412e-03 | 3.000 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.017393e-03 | 2.993 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.098958e-03 | 2.959 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.100119e-03 | 2.959 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.126315e-03 | 2.948 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.170584e-03 | 2.932 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.224676e-03 | 2.912 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.224676e-03 | 2.912 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.286724e-03 | 2.891 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.167110e-03 | 2.933 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.220374e-03 | 2.914 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.291676e-03 | 2.889 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.292681e-03 | 2.889 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.312046e-03 | 2.882 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.325016e-03 | 2.878 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.378239e-03 | 2.861 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.469741e-03 | 2.833 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.665966e-03 | 2.778 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.665966e-03 | 2.778 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.686680e-03 | 2.773 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.686680e-03 | 2.773 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.763668e-03 | 2.754 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.794634e-03 | 2.746 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.992383e-03 | 2.701 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.067655e-03 | 2.685 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.924008e-03 | 2.716 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.082426e-03 | 2.681 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.898992e-03 | 2.721 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.089786e-03 | 2.680 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.944970e-03 | 2.711 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.960575e-03 | 2.708 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.888969e-03 | 2.724 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.122385e-03 | 2.673 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.122385e-03 | 2.673 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.186934e-03 | 2.660 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.202714e-03 | 2.657 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.214104e-03 | 2.655 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.226650e-03 | 2.652 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.226650e-03 | 2.652 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.243722e-03 | 2.649 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.288614e-03 | 2.640 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.293161e-03 | 2.640 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.293161e-03 | 2.640 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.333286e-03 | 2.632 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.333286e-03 | 2.632 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.433023e-03 | 2.614 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.478780e-03 | 2.606 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.548420e-03 | 2.594 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.937357e-03 | 2.532 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.937357e-03 | 2.532 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.937357e-03 | 2.532 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.937357e-03 | 2.532 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.655778e-03 | 2.576 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.655778e-03 | 2.576 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.784828e-03 | 2.555 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.803995e-03 | 2.552 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.924084e-03 | 2.534 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.803995e-03 | 2.552 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.874445e-03 | 2.541 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.594037e-03 | 2.586 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.794039e-03 | 2.554 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.852301e-03 | 2.545 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.952669e-03 | 2.530 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.969876e-03 | 2.527 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.010459e-03 | 2.521 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.010459e-03 | 2.521 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.134408e-03 | 2.504 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.204137e-03 | 2.494 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.211579e-03 | 2.493 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.211579e-03 | 2.493 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.211579e-03 | 2.493 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.226219e-03 | 2.491 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.569278e-03 | 2.447 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.606504e-03 | 2.443 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.650422e-03 | 2.438 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.715195e-03 | 2.430 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.715195e-03 | 2.430 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.829686e-03 | 2.417 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.829686e-03 | 2.417 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.810049e-03 | 2.419 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.755520e-03 | 2.425 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.755520e-03 | 2.425 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.326645e-03 | 2.364 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.301194e-03 | 2.366 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.343951e-03 | 2.362 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.087025e-03 | 2.389 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.952900e-03 | 2.403 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.967272e-03 | 2.402 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.737686e-03 | 2.427 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.810049e-03 | 2.419 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.810049e-03 | 2.419 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.344570e-03 | 2.362 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.501824e-03 | 2.347 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.621079e-03 | 2.335 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.796437e-03 | 2.319 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.827591e-03 | 2.316 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.827591e-03 | 2.316 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.892157e-03 | 2.310 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.071659e-03 | 2.295 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.071659e-03 | 2.295 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.335261e-03 | 2.273 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.335261e-03 | 2.273 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.353698e-03 | 2.271 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.353698e-03 | 2.271 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.585647e-03 | 2.253 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.830037e-03 | 2.234 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.838394e-03 | 2.234 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.838394e-03 | 2.234 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.852244e-03 | 2.233 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.888964e-03 | 2.230 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.888964e-03 | 2.230 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.951850e-03 | 2.225 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.405975e-03 | 2.193 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.513622e-03 | 2.186 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.542156e-03 | 2.184 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.643366e-03 | 2.178 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.814368e-03 | 2.167 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.814658e-03 | 2.167 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.859568e-03 | 2.164 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.882392e-03 | 2.162 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.882392e-03 | 2.162 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.243638e-03 | 2.140 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.243638e-03 | 2.140 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.243638e-03 | 2.140 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.266621e-03 | 2.139 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.266621e-03 | 2.139 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.384946e-03 | 2.132 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.885575e-03 | 2.051 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.885575e-03 | 2.051 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.667768e-03 | 2.115 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.825312e-03 | 2.106 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.000855e-03 | 2.097 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.734858e-03 | 2.112 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.734858e-03 | 2.112 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.042864e-03 | 2.095 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.776441e-03 | 2.109 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.931085e-03 | 2.101 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.851701e-03 | 2.105 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.422177e-03 | 2.075 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.538981e-03 | 2.123 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.405226e-03 | 2.130 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.911532e-03 | 2.102 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.931085e-03 | 2.101 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.987451e-03 | 2.046 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.534361e-03 | 2.021 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.542462e-03 | 2.020 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.542462e-03 | 2.020 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.575638e-03 | 2.019 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 9.575638e-03 | 2.019 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.888069e-03 | 2.005 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.000470e-02 | 2.000 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.000470e-02 | 2.000 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.031136e-02 | 1.987 | 1 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.049468e-02 | 1.979 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.049468e-02 | 1.979 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.065688e-02 | 1.972 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.077244e-02 | 1.968 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.104596e-02 | 1.957 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.134226e-02 | 1.945 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.139893e-02 | 1.943 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.139893e-02 | 1.943 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.184965e-02 | 1.926 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.184965e-02 | 1.926 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.184965e-02 | 1.926 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.184965e-02 | 1.926 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.187466e-02 | 1.925 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.203515e-02 | 1.920 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.212949e-02 | 1.916 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.221636e-02 | 1.913 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.223272e-02 | 1.912 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.241558e-02 | 1.906 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.253248e-02 | 1.902 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.253248e-02 | 1.902 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.261212e-02 | 1.899 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.284782e-02 | 1.891 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.295442e-02 | 1.888 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.295442e-02 | 1.888 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.295442e-02 | 1.888 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.296731e-02 | 1.887 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.349564e-02 | 1.870 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.352359e-02 | 1.869 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.401668e-02 | 1.853 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.402513e-02 | 1.853 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.405983e-02 | 1.852 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.408532e-02 | 1.851 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.607371e-02 | 1.794 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.607371e-02 | 1.794 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.736351e-02 | 1.760 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.714552e-02 | 1.766 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.652909e-02 | 1.782 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.467004e-02 | 1.834 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.545899e-02 | 1.811 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.501568e-02 | 1.823 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.763061e-02 | 1.754 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.652909e-02 | 1.782 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.611048e-02 | 1.793 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.617731e-02 | 1.791 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.662790e-02 | 1.779 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.545899e-02 | 1.811 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.611048e-02 | 1.793 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.543503e-02 | 1.811 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.540781e-02 | 1.812 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.763061e-02 | 1.754 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.686841e-02 | 1.773 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.827518e-02 | 1.738 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.714552e-02 | 1.766 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.652909e-02 | 1.782 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.593980e-02 | 1.798 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.662790e-02 | 1.779 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.763061e-02 | 1.754 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.545899e-02 | 1.811 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.643166e-02 | 1.784 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.848589e-02 | 1.733 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.867096e-02 | 1.729 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.868978e-02 | 1.728 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.877680e-02 | 1.726 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.967744e-02 | 1.706 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.967744e-02 | 1.706 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.967744e-02 | 1.706 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.003971e-02 | 1.698 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.003971e-02 | 1.698 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.044099e-02 | 1.689 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.044099e-02 | 1.689 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.058255e-02 | 1.687 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 2.098395e-02 | 1.678 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.101428e-02 | 1.677 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.103856e-02 | 1.677 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.154556e-02 | 1.667 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.168082e-02 | 1.664 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.174027e-02 | 1.663 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.174027e-02 | 1.663 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.219287e-02 | 1.654 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.219287e-02 | 1.654 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.221818e-02 | 1.653 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.249875e-02 | 1.648 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.249875e-02 | 1.648 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.266381e-02 | 1.645 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.266381e-02 | 1.645 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.306759e-02 | 1.637 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.306759e-02 | 1.637 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.306759e-02 | 1.637 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.329587e-02 | 1.633 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.333975e-02 | 1.632 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.333975e-02 | 1.632 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.365954e-02 | 1.626 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.406589e-02 | 1.619 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.446432e-02 | 1.611 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.517047e-02 | 1.599 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.543322e-02 | 1.595 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.543322e-02 | 1.595 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.543322e-02 | 1.595 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.573218e-02 | 1.590 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.576142e-02 | 1.589 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.614244e-02 | 1.583 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.617672e-02 | 1.582 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.701549e-02 | 1.568 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.705211e-02 | 1.568 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.792516e-02 | 1.554 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.818421e-02 | 1.550 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.838112e-02 | 1.547 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.917575e-02 | 1.535 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.917575e-02 | 1.535 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.924638e-02 | 1.534 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.001160e-02 | 1.523 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.004551e-02 | 1.522 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.004551e-02 | 1.522 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.004551e-02 | 1.522 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.004551e-02 | 1.522 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.055901e-02 | 1.515 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.177584e-02 | 1.498 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.177584e-02 | 1.498 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.177584e-02 | 1.498 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.177584e-02 | 1.498 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.177584e-02 | 1.498 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.451684e-02 | 1.462 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.451684e-02 | 1.462 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.310443e-02 | 1.365 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.229551e-02 | 1.374 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.229551e-02 | 1.374 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.518480e-02 | 1.454 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.380855e-02 | 1.471 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.241530e-02 | 1.489 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.549041e-02 | 1.450 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.796506e-02 | 1.421 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.987363e-02 | 1.399 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.505654e-02 | 1.455 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.066849e-02 | 1.391 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.658946e-02 | 1.437 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.282601e-02 | 1.368 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.380855e-02 | 1.471 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.784398e-02 | 1.422 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.380855e-02 | 1.471 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.281693e-02 | 1.484 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.241530e-02 | 1.489 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.989640e-02 | 1.399 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.525601e-02 | 1.453 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.876057e-02 | 1.412 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.307218e-02 | 1.481 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.310443e-02 | 1.365 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.229551e-02 | 1.374 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.910023e-02 | 1.408 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.860710e-02 | 1.413 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.320094e-02 | 1.479 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.320094e-02 | 1.479 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.465906e-02 | 1.350 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.535161e-02 | 1.343 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.535161e-02 | 1.343 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.601698e-02 | 1.337 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.620569e-02 | 1.335 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.737185e-02 | 1.324 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.847067e-02 | 1.315 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.847067e-02 | 1.315 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.902157e-02 | 1.310 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.902157e-02 | 1.310 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.972929e-02 | 1.303 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.026255e-02 | 1.299 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.026255e-02 | 1.299 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.026255e-02 | 1.299 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.026255e-02 | 1.299 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.126560e-02 | 1.290 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.155385e-02 | 1.288 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.185249e-02 | 1.285 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.185249e-02 | 1.285 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.241756e-02 | 1.281 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.311250e-02 | 1.275 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.385093e-02 | 1.269 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.448987e-02 | 1.264 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.485544e-02 | 1.261 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.531507e-02 | 1.257 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.750717e-02 | 1.240 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.750717e-02 | 1.240 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.750717e-02 | 1.240 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.750717e-02 | 1.240 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.750717e-02 | 1.240 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.750717e-02 | 1.240 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.783474e-02 | 1.238 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.810293e-02 | 1.236 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.867685e-02 | 1.232 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.888161e-02 | 1.230 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.035934e-02 | 1.219 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.035934e-02 | 1.219 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.035934e-02 | 1.219 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.035934e-02 | 1.219 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.035934e-02 | 1.219 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.035934e-02 | 1.219 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.035934e-02 | 1.219 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.035934e-02 | 1.219 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.411640e-02 | 1.193 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.603482e-02 | 1.180 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.641905e-02 | 1.178 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.708936e-02 | 1.173 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.742087e-02 | 1.171 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.756300e-02 | 1.170 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.894975e-02 | 1.161 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.029801e-02 | 1.153 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 7.074454e-02 | 1.150 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 7.074454e-02 | 1.150 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.074454e-02 | 1.150 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.144097e-02 | 1.146 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.154015e-02 | 1.145 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.171286e-02 | 1.144 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.216492e-02 | 1.142 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.281581e-02 | 1.138 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.312780e-02 | 1.136 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.345149e-02 | 1.134 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.410121e-02 | 1.130 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.417088e-02 | 1.130 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.466544e-02 | 1.127 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.552079e-02 | 1.122 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.552079e-02 | 1.122 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.552079e-02 | 1.122 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.731800e-02 | 1.112 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.731800e-02 | 1.112 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.731800e-02 | 1.112 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.147040e-01 | 0.940 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.239825e-02 | 1.084 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 8.239825e-02 | 1.084 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.110820e-01 | 0.954 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.110820e-01 | 0.954 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.110820e-01 | 0.954 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.828197e-02 | 1.008 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.828197e-02 | 1.008 | 1 | 1 |
| ARMS-mediated activation | R-HSA-170984 | 9.828197e-02 | 1.008 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.828197e-02 | 1.008 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.828197e-02 | 1.008 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 9.828197e-02 | 1.008 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.828197e-02 | 1.008 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.507444e-02 | 1.070 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.507444e-02 | 1.070 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.507444e-02 | 1.070 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.507444e-02 | 1.070 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.507444e-02 | 1.070 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.029966e-01 | 0.987 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.731950e-02 | 1.059 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.731950e-02 | 1.059 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.029064e-01 | 0.988 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.187120e-02 | 1.087 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.072777e-01 | 0.969 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.101299e-01 | 0.958 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.072777e-01 | 0.969 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.975339e-02 | 1.098 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.975339e-02 | 1.098 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.413847e-02 | 1.075 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.151180e-02 | 1.089 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.149508e-01 | 0.939 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.914438e-02 | 1.004 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.914438e-02 | 1.004 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.731950e-02 | 1.059 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.696245e-02 | 1.013 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.024435e-01 | 0.990 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.853841e-02 | 1.053 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.029966e-01 | 0.987 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.172625e-01 | 0.931 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.369294e-02 | 1.028 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.915192e-02 | 1.050 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.029064e-01 | 0.988 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.696245e-02 | 1.013 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.072777e-01 | 0.969 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.999008e-02 | 1.097 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.011743e-01 | 0.995 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.187120e-02 | 1.087 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.507444e-02 | 1.070 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.731950e-02 | 1.059 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.914438e-02 | 1.004 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.853841e-02 | 1.053 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.285296e-02 | 1.032 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.814731e-02 | 1.055 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.374844e-02 | 1.028 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.507444e-02 | 1.070 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.176019e-01 | 0.930 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.851307e-02 | 1.053 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.176019e-01 | 0.930 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.176019e-01 | 0.930 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.507444e-02 | 1.070 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.683032e-02 | 1.014 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.172625e-01 | 0.931 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 9.828197e-02 | 1.008 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.166555e-01 | 0.933 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.040327e-01 | 0.983 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.015101e-01 | 0.993 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.101423e-01 | 0.958 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.147040e-01 | 0.940 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.147040e-01 | 0.940 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 9.828197e-02 | 1.008 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.975339e-02 | 1.098 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.172625e-01 | 0.931 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.915192e-02 | 1.050 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.172625e-01 | 0.931 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.027981e-01 | 0.988 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.029966e-01 | 0.987 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.657129e-02 | 1.015 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.731950e-02 | 1.059 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.187120e-02 | 1.087 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.198413e-01 | 0.921 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.198413e-01 | 0.921 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.215841e-01 | 0.915 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.215841e-01 | 0.915 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.215841e-01 | 0.915 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.215841e-01 | 0.915 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.215841e-01 | 0.915 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.215841e-01 | 0.915 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.226257e-01 | 0.911 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.226257e-01 | 0.911 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.242469e-01 | 0.906 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.250089e-01 | 0.903 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.256672e-01 | 0.901 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.258290e-01 | 0.900 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.264946e-01 | 0.898 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.304142e-01 | 0.885 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.306620e-01 | 0.884 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.312903e-01 | 0.882 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.329601e-01 | 0.876 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.339221e-01 | 0.873 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.343869e-01 | 0.872 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.345552e-01 | 0.871 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.345552e-01 | 0.871 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.345552e-01 | 0.871 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.345552e-01 | 0.871 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.345552e-01 | 0.871 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.345552e-01 | 0.871 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.345552e-01 | 0.871 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.345552e-01 | 0.871 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.345552e-01 | 0.871 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.345552e-01 | 0.871 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.345552e-01 | 0.871 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.345552e-01 | 0.871 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.345552e-01 | 0.871 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.345552e-01 | 0.871 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.345552e-01 | 0.871 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.345552e-01 | 0.871 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.345552e-01 | 0.871 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.345552e-01 | 0.871 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.345552e-01 | 0.871 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.345552e-01 | 0.871 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.345552e-01 | 0.871 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.345552e-01 | 0.871 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.345552e-01 | 0.871 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.345552e-01 | 0.871 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.347026e-01 | 0.871 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.380599e-01 | 0.860 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.386520e-01 | 0.858 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.392471e-01 | 0.856 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.392471e-01 | 0.856 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.395445e-01 | 0.855 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.401883e-01 | 0.853 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.426155e-01 | 0.846 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.426155e-01 | 0.846 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.429726e-01 | 0.845 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.429726e-01 | 0.845 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.429726e-01 | 0.845 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.436279e-01 | 0.843 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.463459e-01 | 0.835 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.469914e-01 | 0.833 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.482468e-01 | 0.829 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.482468e-01 | 0.829 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.482468e-01 | 0.829 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.487310e-01 | 0.828 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.547471e-01 | 0.810 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.559751e-01 | 0.807 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.575480e-01 | 0.803 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.597342e-01 | 0.797 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.597342e-01 | 0.797 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.636603e-01 | 0.786 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.636603e-01 | 0.786 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.636603e-01 | 0.786 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.636603e-01 | 0.786 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.636603e-01 | 0.786 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.636603e-01 | 0.786 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.636603e-01 | 0.786 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.636603e-01 | 0.786 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.636603e-01 | 0.786 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.647417e-01 | 0.783 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.652300e-01 | 0.782 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.655190e-01 | 0.781 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.658461e-01 | 0.780 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.659165e-01 | 0.780 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.663065e-01 | 0.779 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.664115e-01 | 0.779 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.665164e-01 | 0.779 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.665164e-01 | 0.779 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.682552e-01 | 0.774 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.689829e-01 | 0.772 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.726542e-01 | 0.763 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.733641e-01 | 0.761 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.742408e-01 | 0.759 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.742408e-01 | 0.759 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.742408e-01 | 0.759 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.742408e-01 | 0.759 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.742408e-01 | 0.759 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.510121e-01 | 0.600 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.510121e-01 | 0.600 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.510121e-01 | 0.600 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.510121e-01 | 0.600 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.510121e-01 | 0.600 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.510121e-01 | 0.600 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.154742e-01 | 0.667 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.154742e-01 | 0.667 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.154742e-01 | 0.667 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.154742e-01 | 0.667 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.154742e-01 | 0.667 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.154742e-01 | 0.667 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.154742e-01 | 0.667 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.518040e-01 | 0.454 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective APRT disrupts adenine salvage | R-HSA-9734195 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.518040e-01 | 0.454 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.518040e-01 | 0.454 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.774544e-01 | 0.751 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.774544e-01 | 0.751 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.774544e-01 | 0.751 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.684912e-01 | 0.571 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.684912e-01 | 0.571 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.684912e-01 | 0.571 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.684912e-01 | 0.571 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.684912e-01 | 0.571 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.684912e-01 | 0.571 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 2.139160e-01 | 0.670 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.139160e-01 | 0.670 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.030509e-01 | 0.692 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.030509e-01 | 0.692 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.030509e-01 | 0.692 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.030509e-01 | 0.692 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.030509e-01 | 0.692 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.030509e-01 | 0.692 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.030509e-01 | 0.692 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.517745e-01 | 0.599 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.517745e-01 | 0.599 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.517745e-01 | 0.599 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.214500e-01 | 0.493 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.214500e-01 | 0.493 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.214500e-01 | 0.493 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.214500e-01 | 0.493 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.214500e-01 | 0.493 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.214500e-01 | 0.493 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.904855e-01 | 0.720 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.904855e-01 | 0.720 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.904855e-01 | 0.720 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.904855e-01 | 0.720 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.780167e-01 | 0.750 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.780167e-01 | 0.750 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.780167e-01 | 0.750 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.904909e-01 | 0.537 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.904909e-01 | 0.537 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.995598e-01 | 0.700 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.220006e-01 | 0.654 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.295788e-01 | 0.482 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.295788e-01 | 0.482 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.295788e-01 | 0.482 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.295788e-01 | 0.482 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.295788e-01 | 0.482 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.959602e-01 | 0.529 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.959602e-01 | 0.529 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.959602e-01 | 0.529 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.959602e-01 | 0.529 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.959602e-01 | 0.529 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.684852e-01 | 0.571 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.452222e-01 | 0.610 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.261646e-01 | 0.646 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.691042e-01 | 0.570 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.281574e-01 | 0.484 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.281574e-01 | 0.484 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.281574e-01 | 0.484 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.790295e-01 | 0.747 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.259836e-01 | 0.646 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.238075e-01 | 0.490 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.068232e-01 | 0.684 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.899579e-01 | 0.538 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.213843e-01 | 0.655 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.519493e-01 | 0.454 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.554429e-01 | 0.593 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.767104e-01 | 0.558 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.434930e-01 | 0.464 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.434930e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.005663e-01 | 0.522 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.488224e-01 | 0.457 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.892470e-01 | 0.723 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.073674e-01 | 0.683 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.416450e-01 | 0.617 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.191174e-01 | 0.659 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.353468e-01 | 0.475 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.922961e-01 | 0.716 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.183607e-01 | 0.497 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.555661e-01 | 0.592 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.030509e-01 | 0.692 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.107405e-01 | 0.508 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.517745e-01 | 0.599 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.416450e-01 | 0.617 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.281574e-01 | 0.484 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.935244e-01 | 0.532 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.124992e-01 | 0.505 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.046671e-01 | 0.689 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.249639e-01 | 0.648 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.916178e-01 | 0.718 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.899579e-01 | 0.538 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.781207e-01 | 0.556 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.275535e-01 | 0.485 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.139160e-01 | 0.670 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.183607e-01 | 0.497 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.416450e-01 | 0.617 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.211509e-01 | 0.655 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.014740e-01 | 0.696 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.406351e-01 | 0.619 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.684912e-01 | 0.571 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.439778e-01 | 0.613 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.654462e-01 | 0.576 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.392062e-01 | 0.621 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.211509e-01 | 0.655 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.524465e-01 | 0.598 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.959349e-01 | 0.529 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.995598e-01 | 0.700 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.995598e-01 | 0.700 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.220006e-01 | 0.654 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.455465e-01 | 0.610 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.935244e-01 | 0.532 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.363520e-01 | 0.626 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.524465e-01 | 0.598 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.959304e-01 | 0.529 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.154742e-01 | 0.667 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.684912e-01 | 0.571 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.684912e-01 | 0.571 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.139160e-01 | 0.670 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.030509e-01 | 0.692 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.452222e-01 | 0.610 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.124992e-01 | 0.505 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.959304e-01 | 0.529 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.129992e-01 | 0.504 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.232361e-01 | 0.490 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.232361e-01 | 0.490 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.065206e-01 | 0.514 | 0 | 0 |
| Translation | R-HSA-72766 | 3.254114e-01 | 0.488 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.588267e-01 | 0.587 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.439778e-01 | 0.613 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.213843e-01 | 0.655 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.005663e-01 | 0.522 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.970418e-01 | 0.705 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.774933e-01 | 0.751 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.904855e-01 | 0.720 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.916178e-01 | 0.718 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.461575e-01 | 0.609 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.073674e-01 | 0.683 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.131468e-01 | 0.504 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.684912e-01 | 0.571 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.214500e-01 | 0.493 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.044441e-01 | 0.689 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.058125e-01 | 0.687 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.354823e-01 | 0.628 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.808189e-01 | 0.552 | 1 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.494450e-01 | 0.457 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.637355e-01 | 0.579 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.815782e-01 | 0.550 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.590574e-01 | 0.587 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.416450e-01 | 0.617 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.333228e-01 | 0.632 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.046671e-01 | 0.689 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.488224e-01 | 0.457 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.073674e-01 | 0.683 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.782821e-01 | 0.749 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.510121e-01 | 0.600 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.154742e-01 | 0.667 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.518040e-01 | 0.454 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.684912e-01 | 0.571 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.517745e-01 | 0.599 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.214500e-01 | 0.493 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.220006e-01 | 0.654 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.295788e-01 | 0.482 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.455465e-01 | 0.610 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.899579e-01 | 0.538 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.052919e-01 | 0.688 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.780167e-01 | 0.750 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.013423e-01 | 0.696 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.996793e-01 | 0.523 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.191174e-01 | 0.659 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.590574e-01 | 0.587 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.590574e-01 | 0.587 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.833932e-01 | 0.548 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.790295e-01 | 0.747 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.275535e-01 | 0.485 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.451430e-01 | 0.611 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.904909e-01 | 0.537 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.104531e-01 | 0.508 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.417937e-01 | 0.617 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.498797e-01 | 0.456 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.857944e-01 | 0.544 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.554429e-01 | 0.593 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.275535e-01 | 0.485 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.157565e-01 | 0.501 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.140549e-01 | 0.669 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.684171e-01 | 0.571 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.452222e-01 | 0.610 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.675580e-01 | 0.573 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.023839e-01 | 0.519 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.204701e-01 | 0.657 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.518040e-01 | 0.454 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.684912e-01 | 0.571 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.214500e-01 | 0.493 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.214500e-01 | 0.493 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.295788e-01 | 0.482 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.434930e-01 | 0.464 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.421803e-01 | 0.616 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.238075e-01 | 0.490 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.211509e-01 | 0.655 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 2.904909e-01 | 0.537 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.259836e-01 | 0.646 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.654462e-01 | 0.576 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.774544e-01 | 0.751 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.684912e-01 | 0.571 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.641957e-01 | 0.578 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.353468e-01 | 0.475 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.774544e-01 | 0.751 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.123317e-01 | 0.505 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.295788e-01 | 0.482 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.574126e-01 | 0.447 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.574126e-01 | 0.447 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.577384e-01 | 0.446 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.584109e-01 | 0.446 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.584109e-01 | 0.446 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.605361e-01 | 0.443 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.605361e-01 | 0.443 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.686095e-01 | 0.433 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.686095e-01 | 0.433 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.686095e-01 | 0.433 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.686095e-01 | 0.433 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.688045e-01 | 0.433 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.688045e-01 | 0.433 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.691776e-01 | 0.433 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.702569e-01 | 0.431 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.702569e-01 | 0.431 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.702569e-01 | 0.431 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.711546e-01 | 0.430 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.711546e-01 | 0.430 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.734068e-01 | 0.428 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.734068e-01 | 0.428 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.734068e-01 | 0.428 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.734068e-01 | 0.428 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.734068e-01 | 0.428 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.734068e-01 | 0.428 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.734068e-01 | 0.428 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.737915e-01 | 0.427 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.756632e-01 | 0.425 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.756632e-01 | 0.425 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.756632e-01 | 0.425 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.771586e-01 | 0.423 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.799005e-01 | 0.420 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.799849e-01 | 0.420 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.801965e-01 | 0.420 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.816042e-01 | 0.418 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.816042e-01 | 0.418 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.816042e-01 | 0.418 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.816042e-01 | 0.418 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.816042e-01 | 0.418 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.881785e-01 | 0.411 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.902622e-01 | 0.409 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.917884e-01 | 0.407 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.928651e-01 | 0.406 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.928651e-01 | 0.406 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.928651e-01 | 0.406 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.928651e-01 | 0.406 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.941830e-01 | 0.404 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.006942e-01 | 0.397 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.048420e-01 | 0.393 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.052674e-01 | 0.392 | 1 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.055324e-01 | 0.392 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.072126e-01 | 0.390 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.072126e-01 | 0.390 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.072126e-01 | 0.390 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.072126e-01 | 0.390 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.072126e-01 | 0.390 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.072126e-01 | 0.390 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.072386e-01 | 0.390 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.116508e-01 | 0.385 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.133501e-01 | 0.384 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.133501e-01 | 0.384 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.195216e-01 | 0.377 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.195216e-01 | 0.377 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.195216e-01 | 0.377 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.195216e-01 | 0.377 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.203712e-01 | 0.376 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.203712e-01 | 0.376 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.236726e-01 | 0.373 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.236726e-01 | 0.373 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.236726e-01 | 0.373 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.236726e-01 | 0.373 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.236726e-01 | 0.373 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.236726e-01 | 0.373 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.236726e-01 | 0.373 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.236726e-01 | 0.373 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.236726e-01 | 0.373 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.236726e-01 | 0.373 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.236726e-01 | 0.373 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.236726e-01 | 0.373 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.249352e-01 | 0.372 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.249352e-01 | 0.372 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.263125e-01 | 0.370 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.280431e-01 | 0.369 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.280431e-01 | 0.369 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.280431e-01 | 0.369 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.301346e-01 | 0.366 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.314394e-01 | 0.365 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.348777e-01 | 0.362 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.390372e-01 | 0.357 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.390372e-01 | 0.357 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.390372e-01 | 0.357 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.390372e-01 | 0.357 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective ADA disrupts (deoxy)adenosine deamination | R-HSA-9734735 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.390372e-01 | 0.357 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.390372e-01 | 0.357 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.390372e-01 | 0.357 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.390372e-01 | 0.357 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.390372e-01 | 0.357 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.390372e-01 | 0.357 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.390372e-01 | 0.357 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.390372e-01 | 0.357 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.399240e-01 | 0.357 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.437120e-01 | 0.353 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.447200e-01 | 0.352 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.450751e-01 | 0.352 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.450751e-01 | 0.352 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.450751e-01 | 0.352 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.450751e-01 | 0.352 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 4.450751e-01 | 0.352 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.450751e-01 | 0.352 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 4.450751e-01 | 0.352 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.450751e-01 | 0.352 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.450751e-01 | 0.352 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.450751e-01 | 0.352 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.511306e-01 | 0.346 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.529551e-01 | 0.344 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.549406e-01 | 0.342 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.565600e-01 | 0.341 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.565600e-01 | 0.341 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.565600e-01 | 0.341 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.565600e-01 | 0.341 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.620827e-01 | 0.335 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.641316e-01 | 0.333 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.641316e-01 | 0.333 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.641316e-01 | 0.333 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.696848e-01 | 0.328 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.696848e-01 | 0.328 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.716364e-01 | 0.326 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.717617e-01 | 0.326 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.717617e-01 | 0.326 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.717617e-01 | 0.326 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.717617e-01 | 0.326 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 4.717617e-01 | 0.326 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.717617e-01 | 0.326 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.717617e-01 | 0.326 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.717617e-01 | 0.326 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.729491e-01 | 0.325 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.740321e-01 | 0.324 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.793100e-01 | 0.319 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.819385e-01 | 0.317 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.819385e-01 | 0.317 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.819385e-01 | 0.317 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.819385e-01 | 0.317 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.819385e-01 | 0.317 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.854685e-01 | 0.314 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.872048e-01 | 0.312 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.875762e-01 | 0.312 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.875762e-01 | 0.312 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.875762e-01 | 0.312 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.875762e-01 | 0.312 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.925877e-01 | 0.308 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.931767e-01 | 0.307 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.940249e-01 | 0.306 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.966801e-01 | 0.304 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.986577e-01 | 0.302 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.986577e-01 | 0.302 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.003717e-01 | 0.301 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.003717e-01 | 0.301 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.003717e-01 | 0.301 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.018895e-01 | 0.299 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.145351e-01 | 0.289 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.145351e-01 | 0.289 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.145351e-01 | 0.289 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 5.145351e-01 | 0.289 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.145351e-01 | 0.289 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.145351e-01 | 0.289 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.145351e-01 | 0.289 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.145351e-01 | 0.289 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.145351e-01 | 0.289 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.145351e-01 | 0.289 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.145351e-01 | 0.289 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.145351e-01 | 0.289 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.145351e-01 | 0.289 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.173497e-01 | 0.286 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.173497e-01 | 0.286 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 5.173497e-01 | 0.286 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.173497e-01 | 0.286 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.173497e-01 | 0.286 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.173497e-01 | 0.286 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.173497e-01 | 0.286 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.173497e-01 | 0.286 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.173497e-01 | 0.286 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.173497e-01 | 0.286 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.173497e-01 | 0.286 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.173497e-01 | 0.286 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.175946e-01 | 0.286 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.175946e-01 | 0.286 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.175946e-01 | 0.286 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.175946e-01 | 0.286 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.175946e-01 | 0.286 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.178436e-01 | 0.286 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.178436e-01 | 0.286 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.178436e-01 | 0.286 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.178436e-01 | 0.286 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.178436e-01 | 0.286 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.181804e-01 | 0.286 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.181804e-01 | 0.286 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.181804e-01 | 0.286 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.185780e-01 | 0.285 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.185780e-01 | 0.285 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.190124e-01 | 0.285 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.194677e-01 | 0.284 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.199342e-01 | 0.284 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.208780e-01 | 0.283 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.227375e-01 | 0.282 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.380218e-01 | 0.269 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.399709e-01 | 0.268 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.409722e-01 | 0.267 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.409722e-01 | 0.267 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.409722e-01 | 0.267 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.423582e-01 | 0.266 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.443267e-01 | 0.264 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.443267e-01 | 0.264 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.443267e-01 | 0.264 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.502607e-01 | 0.259 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.514750e-01 | 0.258 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.518814e-01 | 0.258 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.518814e-01 | 0.258 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.518814e-01 | 0.258 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.518814e-01 | 0.258 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.518814e-01 | 0.258 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.518814e-01 | 0.258 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.518814e-01 | 0.258 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.601240e-01 | 0.252 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.601240e-01 | 0.252 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.602389e-01 | 0.252 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.602389e-01 | 0.252 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.602389e-01 | 0.252 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.602389e-01 | 0.252 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.602389e-01 | 0.252 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.602389e-01 | 0.252 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.602389e-01 | 0.252 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.602389e-01 | 0.252 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.602389e-01 | 0.252 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.603141e-01 | 0.252 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.625081e-01 | 0.250 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.625081e-01 | 0.250 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.625081e-01 | 0.250 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.656086e-01 | 0.247 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.656086e-01 | 0.247 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.697809e-01 | 0.244 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.697809e-01 | 0.244 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.750446e-01 | 0.240 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.756796e-01 | 0.240 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.756796e-01 | 0.240 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.756796e-01 | 0.240 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.756796e-01 | 0.240 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.756796e-01 | 0.240 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.769217e-01 | 0.239 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.769217e-01 | 0.239 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.798758e-01 | 0.237 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.798758e-01 | 0.237 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.798758e-01 | 0.237 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.798758e-01 | 0.237 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.798758e-01 | 0.237 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.798758e-01 | 0.237 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.798758e-01 | 0.237 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.798758e-01 | 0.237 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.798758e-01 | 0.237 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.798758e-01 | 0.237 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.846779e-01 | 0.233 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.862044e-01 | 0.232 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.862044e-01 | 0.232 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.862044e-01 | 0.232 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.882747e-01 | 0.230 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.882747e-01 | 0.230 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.944778e-01 | 0.226 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.979431e-01 | 0.223 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.992274e-01 | 0.222 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.998837e-01 | 0.222 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.998837e-01 | 0.222 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.003299e-01 | 0.222 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.003299e-01 | 0.222 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.003299e-01 | 0.222 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.041307e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.095586e-01 | 0.215 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.103101e-01 | 0.214 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.103101e-01 | 0.214 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.158993e-01 | 0.210 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.158993e-01 | 0.210 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.158993e-01 | 0.210 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.158993e-01 | 0.210 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.181115e-01 | 0.209 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.181115e-01 | 0.209 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.288385e-01 | 0.201 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.293657e-01 | 0.201 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.293657e-01 | 0.201 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.364253e-01 | 0.196 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.364253e-01 | 0.196 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.364253e-01 | 0.196 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.364253e-01 | 0.196 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.364253e-01 | 0.196 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.364253e-01 | 0.196 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.364253e-01 | 0.196 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.364253e-01 | 0.196 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.364253e-01 | 0.196 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.364253e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.364253e-01 | 0.196 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.364253e-01 | 0.196 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.364253e-01 | 0.196 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.364253e-01 | 0.196 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.364253e-01 | 0.196 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 6.364253e-01 | 0.196 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.373146e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.373146e-01 | 0.196 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.375990e-01 | 0.195 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.375990e-01 | 0.195 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.375990e-01 | 0.195 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.375990e-01 | 0.195 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.375990e-01 | 0.195 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.375990e-01 | 0.195 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.435784e-01 | 0.191 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.435784e-01 | 0.191 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.435784e-01 | 0.191 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.435784e-01 | 0.191 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.454925e-01 | 0.190 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.454925e-01 | 0.190 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.454925e-01 | 0.190 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.454925e-01 | 0.190 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.454925e-01 | 0.190 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.454925e-01 | 0.190 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.454925e-01 | 0.190 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.523388e-01 | 0.186 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.523388e-01 | 0.186 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.523388e-01 | 0.186 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.523388e-01 | 0.186 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.545138e-01 | 0.184 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.545138e-01 | 0.184 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.545138e-01 | 0.184 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.545138e-01 | 0.184 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.581033e-01 | 0.182 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.587778e-01 | 0.181 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.606178e-01 | 0.180 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.624154e-01 | 0.179 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.631841e-01 | 0.178 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.635417e-01 | 0.178 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.635417e-01 | 0.178 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.635417e-01 | 0.178 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.635417e-01 | 0.178 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.720795e-01 | 0.173 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.720795e-01 | 0.173 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.720795e-01 | 0.173 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.720795e-01 | 0.173 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.734313e-01 | 0.172 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.734313e-01 | 0.172 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.734313e-01 | 0.172 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.734313e-01 | 0.172 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.734313e-01 | 0.172 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.736580e-01 | 0.172 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.784896e-01 | 0.168 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.784896e-01 | 0.168 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.784896e-01 | 0.168 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 6.803654e-01 | 0.167 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.847772e-01 | 0.164 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.853660e-01 | 0.164 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.853660e-01 | 0.164 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.853660e-01 | 0.164 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.853660e-01 | 0.164 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.853660e-01 | 0.164 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.853660e-01 | 0.164 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.853660e-01 | 0.164 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.853660e-01 | 0.164 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.853660e-01 | 0.164 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.853660e-01 | 0.164 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.853660e-01 | 0.164 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.853660e-01 | 0.164 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.853660e-01 | 0.164 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.853660e-01 | 0.164 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.853660e-01 | 0.164 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.853660e-01 | 0.164 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.853660e-01 | 0.164 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.853660e-01 | 0.164 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.975669e-01 | 0.156 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.997126e-01 | 0.155 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.997126e-01 | 0.155 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.997126e-01 | 0.155 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.997126e-01 | 0.155 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.012787e-01 | 0.154 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.012787e-01 | 0.154 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.012787e-01 | 0.154 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.034825e-01 | 0.153 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.038466e-01 | 0.153 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.038466e-01 | 0.153 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.038466e-01 | 0.153 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.050878e-01 | 0.152 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.050878e-01 | 0.152 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.050878e-01 | 0.152 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.113997e-01 | 0.148 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.171985e-01 | 0.144 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.228779e-01 | 0.141 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.228779e-01 | 0.141 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.228779e-01 | 0.141 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.228779e-01 | 0.141 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.228779e-01 | 0.141 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.243521e-01 | 0.140 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.243521e-01 | 0.140 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.243521e-01 | 0.140 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 7.277212e-01 | 0.138 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 7.277212e-01 | 0.138 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.277212e-01 | 0.138 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.277212e-01 | 0.138 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.277212e-01 | 0.138 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.277212e-01 | 0.138 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.277212e-01 | 0.138 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.277212e-01 | 0.138 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.277212e-01 | 0.138 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.277212e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.314372e-01 | 0.136 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.317284e-01 | 0.136 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.330061e-01 | 0.135 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.330061e-01 | 0.135 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.330061e-01 | 0.135 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.330061e-01 | 0.135 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.429121e-01 | 0.129 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.432947e-01 | 0.129 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.432947e-01 | 0.129 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.432947e-01 | 0.129 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.432947e-01 | 0.129 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.444500e-01 | 0.128 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.473812e-01 | 0.126 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.473812e-01 | 0.126 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.541506e-01 | 0.123 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.596841e-01 | 0.119 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.596841e-01 | 0.119 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.596841e-01 | 0.119 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.596841e-01 | 0.119 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.605747e-01 | 0.119 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.617284e-01 | 0.118 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.625448e-01 | 0.118 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.643086e-01 | 0.117 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.643086e-01 | 0.117 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.643086e-01 | 0.117 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.643086e-01 | 0.117 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.643086e-01 | 0.117 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.643768e-01 | 0.117 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 7.643768e-01 | 0.117 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.643768e-01 | 0.117 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.643768e-01 | 0.117 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.643768e-01 | 0.117 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.643768e-01 | 0.117 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.643768e-01 | 0.117 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.643768e-01 | 0.117 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.643768e-01 | 0.117 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.643768e-01 | 0.117 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.643768e-01 | 0.117 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.643768e-01 | 0.117 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.643768e-01 | 0.117 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.643768e-01 | 0.117 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.643768e-01 | 0.117 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.643768e-01 | 0.117 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.688435e-01 | 0.114 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.688435e-01 | 0.114 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.688435e-01 | 0.114 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.688435e-01 | 0.114 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.688435e-01 | 0.114 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.688435e-01 | 0.114 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.759371e-01 | 0.110 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.806518e-01 | 0.108 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.840204e-01 | 0.106 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.840204e-01 | 0.106 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.840204e-01 | 0.106 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.840204e-01 | 0.106 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.840204e-01 | 0.106 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.887926e-01 | 0.103 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.960994e-01 | 0.099 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.960994e-01 | 0.099 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.960994e-01 | 0.099 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.960994e-01 | 0.099 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.960994e-01 | 0.099 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.960994e-01 | 0.099 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.960994e-01 | 0.099 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.960994e-01 | 0.099 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.960994e-01 | 0.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.960994e-01 | 0.099 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.960994e-01 | 0.099 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.960994e-01 | 0.099 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.960994e-01 | 0.099 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.960994e-01 | 0.099 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.960994e-01 | 0.099 | 0 | 0 |
| Calcitonin-like ligand receptors | R-HSA-419812 | 7.960994e-01 | 0.099 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.976448e-01 | 0.098 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.976448e-01 | 0.098 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.030600e-01 | 0.095 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.061616e-01 | 0.094 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.061616e-01 | 0.094 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.061616e-01 | 0.094 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.063849e-01 | 0.093 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.072895e-01 | 0.093 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.072895e-01 | 0.093 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.072895e-01 | 0.093 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.072895e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.215327e-01 | 0.085 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.235527e-01 | 0.084 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.235527e-01 | 0.084 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.235527e-01 | 0.084 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.235527e-01 | 0.084 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.235527e-01 | 0.084 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.235527e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.244001e-01 | 0.084 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.244001e-01 | 0.084 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.244001e-01 | 0.084 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.262578e-01 | 0.083 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.262578e-01 | 0.083 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.262578e-01 | 0.083 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.262578e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.262578e-01 | 0.083 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.262578e-01 | 0.083 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.284308e-01 | 0.082 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.299950e-01 | 0.081 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.401944e-01 | 0.076 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.401944e-01 | 0.076 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.401944e-01 | 0.076 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.401944e-01 | 0.076 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.423033e-01 | 0.075 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.423033e-01 | 0.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.423033e-01 | 0.075 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.444580e-01 | 0.073 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.446198e-01 | 0.073 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.452623e-01 | 0.073 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.470070e-01 | 0.072 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.470070e-01 | 0.072 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.470070e-01 | 0.072 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.473111e-01 | 0.072 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.473111e-01 | 0.072 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.473111e-01 | 0.072 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.473111e-01 | 0.072 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.473111e-01 | 0.072 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.473111e-01 | 0.072 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.473111e-01 | 0.072 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.473111e-01 | 0.072 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.473111e-01 | 0.072 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.473111e-01 | 0.072 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.490450e-01 | 0.071 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.504697e-01 | 0.070 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.535396e-01 | 0.069 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.547439e-01 | 0.068 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.547439e-01 | 0.068 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.578033e-01 | 0.067 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.585710e-01 | 0.066 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.587381e-01 | 0.066 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.590791e-01 | 0.066 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.609085e-01 | 0.065 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.609085e-01 | 0.065 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.609085e-01 | 0.065 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.609085e-01 | 0.065 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.609085e-01 | 0.065 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.610487e-01 | 0.065 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.678716e-01 | 0.062 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.678716e-01 | 0.062 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.678716e-01 | 0.062 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.678716e-01 | 0.062 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.678716e-01 | 0.062 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.678716e-01 | 0.062 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 8.678716e-01 | 0.062 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.678716e-01 | 0.062 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.678716e-01 | 0.062 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.678716e-01 | 0.062 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.678716e-01 | 0.062 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.678716e-01 | 0.062 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.685627e-01 | 0.061 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.685627e-01 | 0.061 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.693942e-01 | 0.061 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.717138e-01 | 0.060 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.757503e-01 | 0.058 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.757503e-01 | 0.058 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.757503e-01 | 0.058 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.783623e-01 | 0.056 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.783624e-01 | 0.056 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.783624e-01 | 0.056 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.803991e-01 | 0.055 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.822015e-01 | 0.054 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.856646e-01 | 0.053 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.856646e-01 | 0.053 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.856646e-01 | 0.053 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.856646e-01 | 0.053 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.856646e-01 | 0.053 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.856646e-01 | 0.053 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.886812e-01 | 0.051 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.886812e-01 | 0.051 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.889470e-01 | 0.051 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.891183e-01 | 0.051 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.891183e-01 | 0.051 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.891183e-01 | 0.051 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.908706e-01 | 0.050 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.982258e-01 | 0.047 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.990445e-01 | 0.046 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.010623e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.010623e-01 | 0.045 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.010623e-01 | 0.045 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 9.010623e-01 | 0.045 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.010623e-01 | 0.045 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.010623e-01 | 0.045 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.010623e-01 | 0.045 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.011402e-01 | 0.045 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.011402e-01 | 0.045 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.011402e-01 | 0.045 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.011402e-01 | 0.045 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.011402e-01 | 0.045 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.019393e-01 | 0.045 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.066234e-01 | 0.043 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.070416e-01 | 0.042 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.070416e-01 | 0.042 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.070416e-01 | 0.042 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.077170e-01 | 0.042 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.119361e-01 | 0.040 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.119361e-01 | 0.040 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.119361e-01 | 0.040 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.119361e-01 | 0.040 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.119361e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.119361e-01 | 0.040 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.137056e-01 | 0.039 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.143872e-01 | 0.039 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 9.143872e-01 | 0.039 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.143872e-01 | 0.039 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.143872e-01 | 0.039 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.143872e-01 | 0.039 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.203159e-01 | 0.036 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.216181e-01 | 0.035 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.216181e-01 | 0.035 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.216181e-01 | 0.035 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.226624e-01 | 0.035 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.246677e-01 | 0.034 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.259182e-01 | 0.033 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.259182e-01 | 0.033 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.259182e-01 | 0.033 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 9.259182e-01 | 0.033 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.259182e-01 | 0.033 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.259182e-01 | 0.033 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.259182e-01 | 0.033 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.259182e-01 | 0.033 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.259182e-01 | 0.033 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.259182e-01 | 0.033 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.259182e-01 | 0.033 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.259182e-01 | 0.033 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.259182e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.259182e-01 | 0.033 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.264786e-01 | 0.033 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.264786e-01 | 0.033 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.281094e-01 | 0.032 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.302903e-01 | 0.031 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.302903e-01 | 0.031 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.348248e-01 | 0.029 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.358966e-01 | 0.029 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.358966e-01 | 0.029 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.358966e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.358966e-01 | 0.029 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.380490e-01 | 0.028 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.380490e-01 | 0.028 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.380490e-01 | 0.028 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.388034e-01 | 0.027 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.395826e-01 | 0.027 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.412789e-01 | 0.026 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.412789e-01 | 0.026 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.412789e-01 | 0.026 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.421101e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.441733e-01 | 0.025 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.445316e-01 | 0.025 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.445316e-01 | 0.025 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.445316e-01 | 0.025 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.445316e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.445316e-01 | 0.025 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.445316e-01 | 0.025 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.449830e-01 | 0.025 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.449830e-01 | 0.025 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.497414e-01 | 0.022 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.497742e-01 | 0.022 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.503844e-01 | 0.022 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.511735e-01 | 0.022 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.516466e-01 | 0.022 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.518936e-01 | 0.021 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.518936e-01 | 0.021 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.520038e-01 | 0.021 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.520038e-01 | 0.021 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.520038e-01 | 0.021 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.520038e-01 | 0.021 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.520038e-01 | 0.021 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.520038e-01 | 0.021 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.520038e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.520038e-01 | 0.021 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.520038e-01 | 0.021 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.538013e-01 | 0.021 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.543368e-01 | 0.020 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.544218e-01 | 0.020 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.544691e-01 | 0.020 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.566951e-01 | 0.019 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.566951e-01 | 0.019 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.566951e-01 | 0.019 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.566951e-01 | 0.019 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.572531e-01 | 0.019 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.584697e-01 | 0.018 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.584697e-01 | 0.018 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.584697e-01 | 0.018 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.584697e-01 | 0.018 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.595836e-01 | 0.018 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.609610e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.609610e-01 | 0.017 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.612669e-01 | 0.017 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.616021e-01 | 0.017 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.624065e-01 | 0.017 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.629949e-01 | 0.016 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.640650e-01 | 0.016 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.640650e-01 | 0.016 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.640650e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.640650e-01 | 0.016 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.640650e-01 | 0.016 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.640650e-01 | 0.016 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.641493e-01 | 0.016 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.643939e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.655324e-01 | 0.015 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.655324e-01 | 0.015 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.655324e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.655324e-01 | 0.015 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.655324e-01 | 0.015 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.659965e-01 | 0.015 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.671907e-01 | 0.014 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.675468e-01 | 0.014 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.675468e-01 | 0.014 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.689066e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.689066e-01 | 0.014 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.689066e-01 | 0.014 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.689066e-01 | 0.014 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.689066e-01 | 0.014 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.689066e-01 | 0.014 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.689066e-01 | 0.014 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.698942e-01 | 0.013 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.704399e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.706335e-01 | 0.013 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.710157e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.722818e-01 | 0.012 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.722818e-01 | 0.012 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.722818e-01 | 0.012 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.722818e-01 | 0.012 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.730924e-01 | 0.012 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.730962e-01 | 0.012 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.730962e-01 | 0.012 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.730962e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.730962e-01 | 0.012 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.730962e-01 | 0.012 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.730962e-01 | 0.012 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.730962e-01 | 0.012 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.730962e-01 | 0.012 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.730962e-01 | 0.012 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.755223e-01 | 0.011 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.767215e-01 | 0.010 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.767215e-01 | 0.010 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.767215e-01 | 0.010 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.767215e-01 | 0.010 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.767215e-01 | 0.010 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.767215e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.767215e-01 | 0.010 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.767215e-01 | 0.010 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.777649e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.791696e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.791696e-01 | 0.009 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.791696e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.793947e-01 | 0.009 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.798584e-01 | 0.009 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.798584e-01 | 0.009 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.798584e-01 | 0.009 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.798584e-01 | 0.009 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.798584e-01 | 0.009 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.801026e-01 | 0.009 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.805557e-01 | 0.009 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.805557e-01 | 0.009 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.815937e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.815937e-01 | 0.008 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.815937e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.816394e-01 | 0.008 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.822046e-01 | 0.008 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.825728e-01 | 0.008 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.825728e-01 | 0.008 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.825728e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.833369e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.837429e-01 | 0.007 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.846719e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.846719e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.849215e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.849215e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.849215e-01 | 0.007 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.849215e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.849215e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.849215e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.849215e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.851617e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.856474e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.857889e-01 | 0.006 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.869538e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.869538e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.869538e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.869538e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.871012e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.871012e-01 | 0.006 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.873103e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.873339e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.873339e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.873717e-01 | 0.006 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.887123e-01 | 0.005 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.887123e-01 | 0.005 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.887123e-01 | 0.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.887123e-01 | 0.005 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.887123e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.887581e-01 | 0.005 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.888266e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.895573e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.901472e-01 | 0.004 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.902338e-01 | 0.004 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.902338e-01 | 0.004 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.915504e-01 | 0.004 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.915504e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.915504e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.915504e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.915504e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.923469e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.924777e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.926441e-01 | 0.003 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.926895e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.926895e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.928452e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.931996e-01 | 0.003 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.932586e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.932586e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.932586e-01 | 0.003 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.936751e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.936751e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.936751e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.936751e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.938644e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.940636e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.940801e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.945279e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.950046e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.950895e-01 | 0.002 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.952657e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.953711e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.954010e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.955905e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.955905e-01 | 0.002 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.957130e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.959041e-01 | 0.002 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.959539e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.960575e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.964507e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.964564e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.964696e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.964696e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.967586e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.968398e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.968710e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.970403e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.973478e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.973478e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.973478e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.974709e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.978763e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.979042e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.980150e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.980150e-01 | 0.001 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.980150e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.980261e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.980454e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.981445e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.981759e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.982827e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.982827e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.983873e-01 | 0.001 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.985144e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.985490e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.986378e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.986378e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.986948e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.988882e-01 | 0.000 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.988882e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.989847e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.990382e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.990532e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.991474e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.991618e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991728e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.992401e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.993774e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.993774e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.994135e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.994252e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.994614e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.994614e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.994962e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.996984e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997391e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.997391e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997724e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997724e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.998000e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998007e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998048e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.998048e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998319e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998429e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.998540e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.998664e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998846e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998897e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.998907e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999055e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999213e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999218e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999276e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999389e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999395e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999477e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999543e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999618e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999679e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999704e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999741e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999761e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999807e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999874e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999876e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999893e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999920e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999920e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999968e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999975e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999978e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999980e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999991e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999992e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999994e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999995e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999996e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999998e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999998e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |